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Abstract
In recent years, methicillin-resistant Staphylococcus aureus (MRSA) have become a truly global challenge. In addition to the
long-known healthcare-associated clones, novel strains have also emerged outside of the hospital settings, in the
community as well as in livestock. The emergence and spread of virulent clones expressing Panton-Valentine leukocidin
(PVL) is an additional cause for concern. In order to provide an overview of pandemic, epidemic and sporadic strains, more
than 3,000 clinical and veterinary isolates of MRSA mainly from Germany, the United Kingdom, Ireland, France, Malta, Abu
Dhabi, Hong Kong, Australia, Trinidad & Tobago as well as some reference strains from the United States have been
genotyped by DNA microarray analysis. This technique allowed the assignment of the MRSA isolates to 34 distinct lineages
which can be clearly defined based on non-mobile genes. The results were in accordance with data from multilocus
sequence typing. More than 100 different strains were distinguished based on affiliation to these lineages, SCCmec type and
the presence or absence of PVL. These strains are described here mainly with regard to clinically relevant antimicrobial
resistance- and virulence-associated markers, but also in relation to epidemiology and geographic distribution. The findings
of the study show a high level of biodiversity among MRSA, especially among strains harbouring SCCmec IV and V elements.
The data also indicate a high rate of genetic recombination in MRSA involving SCC elements, bacteriophages or other
mobile genetic elements and large-scale chromosomal replacements.
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Introduction
Staphylococcus aureus is a ubiquitous bacterium colonising 20–30%
of the human population [1]. Beyond asymptomatic carriage, S.
aureus causes a wide range of infections, such as skin and soft tissue
infections (SSTI), bone, joint and implant infections, pneumonia,
septicaemia and various toxicoses such as toxic shock syndrome. It
also occurs in many different species of animals, where it may
cause comparable disease such as bovine mastitis.
Shortly after the introduction of penicillin in the 1940s, the first
penicillinase-producing S. aureus strains were detected, leading to
the development of the penicillinase-resistant semi-synthetic
penicillins such as methicillin, oxacillin and the first/second
generation cephalosporins. Within a year after the introduction of
these drugs, methicillin-resistant S. aureus (MRSA) were reported in
the United Kingdom (UK) [2]. Resistance is due to a modified
penicillin binding protein (PBP2’ or PBP2a) encoded by the mecA
gene. Apart from ceftobiprole [3], the presence of PBP2a confers
resistance towards all b-lactam antibiotics. As methicillin and
oxacillin can be used as indicators of resistance, PBP2a- or mecA-
positive S. aureus are referred to as either methicillin-resistant S.
aureus (MRSA) or oxacillin-resistant S. aureus (ORSA). The mecA
gene is located on complex mobile genetic elements, known as
SCCmec (‘‘staphylococcal cassette chromosome’’ or ‘‘staphylococ-
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cal chromosomal cassette’’ harbouring mecA). In addition to mecA,
SCCmec elements comprise recombinase genes, regulatory ele-
ments and, variably, additional genes encoding resistance to other
antimicrobials, such as aminoglycosides or macrolides, and to
heavy metal ions [4; 5]. SCCmec types I, II and III (or 1B, 2A, 3A,
[6]) are typically restricted to MRSA strains associated with
healthcare infections and are not found widely among the healthy
population. These strains, which initially were known as
‘‘Epidemic MRSA’’ (EMRSA), are now frequently referred to as
‘‘hospital-acquired’’ or ‘‘healthcare-associated’’ MRSA (HA-
MRSA). The presence of their SCCmec elements correlates with
a relatively slower growth rate and it has been assumed that they
may confer a selective disadvantage in the absence of antibiotics
[7; 8]. Subsequently, strains carrying these elements may be less fit
to survive in a competitive environment with faster growing wild
type strains once antibiotic therapy is discontinued.
The epidemiology of MRSA has changed since the 1990s with
the emergence of new SCCmec elements such as types IV and V
(2B, 5C2). Strains carrying these elements evolved predominantly
outside of healthcare settings or proved capable of spreading
outside of hospitals, infecting not only patients but also colonising
healthy contact persons. Many different strains of so-called
‘‘community-acquired’’ or ‘‘community-associated’’ MRSA (CA-
MRSA) have spread worldwide. Some CA-MRSA strains harbour
genes encoding the bi-component toxin Panton-Valentine leuko-
cidin (PVL, [9]). Although this toxin was identified in S. aureus as
early as 1932 [10], its presence in MRSA is a very recent
phenomenon [11]. These strains are frequently associated with
chronic/recurrent SSTI as well as with life-threatening necrotising
pneumonia [12], often in previously healthy young people. PVL-
positive CA-MRSA have become a serious public health concern
because of their virulence, their ability to cause outbreaks in
households and close contact social groups, and their rapid spread
in many countries.
Since 2003, some notable MRSA strains carrying SCCmec IV or
V have spread among livestock revealing the truly zoonotic
potential of S. aureus/MRSA. These strains have been dubbed
‘‘livestock-associated‘‘ MRSA (LA-MRSA, [13]).
Additional novel SCCmec elements have been described
[6;14–17] which indicate an ongoing evolution of antibiotic
resistance in S. aureus. As b-lactam antibiotics are the first-line
compounds for treatment of staphylococcal infections, this
development may significantly limit therapeutic options. Alterna-
tive drugs that may be used to treat MRSA infections are generally
expensive (e.g., quinupristin-dalfopristin, tigecycline, daptomycin
and linezolid), or are problematic with regard to tissue penetration
and efficiency (e.g., vancomycin) or toxicity (e.g., rifampicin). Of
further concern is that resistance of MRSA to these compounds
has already been observed, e.g., vanA-mediated vancomycin
resistance [18] and cfr-mediated linezolid resistance [19–21].
The limited choice of therapeutic options available has made it
necessary to attempt to limit the spread of MRSA by using a range
of infection prevention and control measures such as hand
hygiene, the use of protective clothing and equipment (e.g.,
examination gloves or face masks), and accommodation of patients
in isolation rooms or wards. The cost of these measures as well as
the significant expense of second-line antimicrobials places a
serious economic burden on scarce healthcare resources. Recent
studies from Europe indicated that the average excess costs per
MRSA-positive patient range from J5,700 to J10,000 [22–24].
Given the large number of MRSA carriers in Europe and in the
USA, the financial burden to healthcare in these regions may
account for billions of Euro or dollars (http://www.infectioncon
troltoday.com/hotnews/55h168584264313.html).
MRSA have become a real international problem. Some strains
predominate in geographically restricted settings while others have
achieved pandemic spread. Since a bewildering biodiversity of
novel strains and SCCmec elements has been described in recent
years, the objective of this study is to summarise the genotypic
characteristics of pandemic, epidemic and sporadic MRSA strains
from different parts of the world based on the authors’ genotyping
experiments and on the published literature.
Results
Information on target genes, probes and primers is provided in
Supplemental file S1. The sequence types (ST, as defined by
multilocus sequence typing, or MLST, [25]), spa, SCCmec, capsule
and agr types associated with each clonal complex (CC) as well as
the names and accession numbers of associated whole genome
sequenced strains are shown in Supplemental file S2. An overview
of SCCmec types and their array hybridisation patterns is provided
in Figure 1. The antimicrobial resistance and virulence-associated
genes of each strain are shown in Figures 2 and 3, respectively,
while complete hybridisation profiles for the individual strains are
provided in Supplemental file S3.
Clonal complex 1
CC1 includes several strains of CA-MRSA including MW2/
USA400, the first known PVL-positive MRSA [11]. The CC1
strains ST573 and ST772 differ significantly in MLST alleles to all
other CC1 isolates and yield deviant hybridisation patterns.
Therefore they will be described separately (see below). The
remaining CC1-MRSA cluster into seven strains that can be
differentiated based on the presence of the PVL genes, SCCmec
elements IV or V and the SCCfus element. The latter comprises
ccrA-1 and ccrB-1 as well as the fusidic acid resistance marker
Q6GD50 (GenBank BX571857.1:SAS0043) first described in the
genome sequence of the CC1-MSSA strain Sanger MSSA 476
[26]. All isolates of these CC1-MRSA strains harbour the
enterotoxin gene seh and many isolates also carry the enterotoxin
genes sek and seq. Other enterotoxin genes (sea-N315, seb, sec and sel)
are only found sporadically. Most isolates harbour the immune
evasion cluster (IEC) genes associated with b-haemolysin-convert-
ing phages in various combinations.
One CC1-MRSA strain carries SCCmec IV and PVL, but lacks
SCCfus. The genome sequence of MW2 [27] is a representative of
this strain, which is also known as USA400 or Canadian MRSA-7
[28]. The first known PVL-positive CA-MRSA belonged to this
strain. In the late 1990s, it caused fatal infections in previously
healthy children from Minnesota and North Dakota [11]. The
authors sporadically found isolates in Australia, Germany and the
UK.
A second strain also carries SCCmec IV, lacks SCCfus, but
differs from USA400 in being PVL-negative. It has been found by
the authors primarily in Australia where it is designated as West
Australian (WA) MRSA-57 although it also includes some of the
isolates originally described as WA MRSA-1. It has been isolated
sporadically in Saxony (Germany, [29]), Ireland [30] and Egypt
(isolate courtesy of M. Kamal El Din, Cairo).
A third strain is PVL-negative, but harbours both, SCCmec IV
and SCCfus. It includes WA MRSA-45 and also some WA
MRSA-1 isolates. It has been isolated in Australia as well as,
sporadically, in Abu Dhabi (United Arab Emirates [31]), the UK
and Ireland [30].
Sporadic isolates of PVL-positive CC1-MRSA-IV with SCCfus,
PVL-positive CC1-MRSA-V and PVL-negative CC1-MRSA-V
with SCCfus have been isolated from a small number of cases in
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Australia. A PVL-positive CC1-MRSA-V with SCCfus has been
found in Abu Dhabi [31].
Clonal complex 5
CC5 is another common and widespread clonal complex,
which comprises a large number of different MRSA strains, both
HA- and CA-MRSA, some of which have attained pandemic
spread.
Several whole genome sequences are available (Supplemental
file S2) which comprise the features of the CC5 core genome
including characteristic allelic variants of the ssl/set genes and of
genes encoding microbial surface components recognising adhe-
sive matrix molecules of the host (MSCRAMM genes). CC5
isolates carry the enterotoxin gene cluster egc (seg, sei, sem, sen, seo
and seu/y), although partial deletions have been observed. b-
haemolysin-converting phages carrying sak, scn and chp as well as
sea or sea-N315 in various combinations are commonly detected.
Many variable virulence- or resistance-associated genes and
several different SCCmec elements have been found in CC5.
ST228-MRSA-I is colloquially known as the South German
Epidemic Strain, Italian Clone, [32;33] or Spanish PFGE types
E6/9/15/17/18 [34]. The strain occurs in Germany (where it
appears to be a strictly HA-MRSA strain, although its incidence is
decreasing), Hungary (where it replaced the ‘‘Hungarian Clone’’
ST239-MRSA-III, [35]), Italy [32;33;36], Slovenia [36] and
Switzerland [37]. It was also found sporadically in Austria [38],
Israel [39], Malta [40] and Australia. MLST variants of this strain
have been described from Croatia (ST111, [41]) and Paraguay
(ST5, ST221, [42]). The isolates harbour SCCmec I. A variant
lacking ccrA/B-1 was identified in Saxony in 2000. Variable
markers [43] include the mercury resistance operon, the b-
lactamase operon as well as several other resistance genes
(Figure 2), the toxic shock syndrome toxin tst1, IEC genes and
the MSCRAMM genes bbp, clfA and sdrD. In contrast to other
CC5 strains, ST228-MRSA-I lacks fnbB, a gene encoding a
fibronectin-binding protein. Deletions of the leukocidin genes
lukD+lukE and of neighbouring genes from the egc locus are
common [43].
A ST5-MRSA-I, known as the Geraldine Clone, is a second
SCCmec I strain from CC5. This is a common CA-MRSA clone in
France [44]. Apart from a single veterinary isolate from Germany
(courtesy of B. Walther, FU Berlin), isolates have not been
detected outside of France. Unlike ST228-MRSA-I, Geraldine
Clone isolates harbour Q6GD50, enterotoxin genes sed, sej and ser
and fnbB. Most isolates carry tst1 and the enterotoxin genes sec and
sel. The SCCmec element lacks pls-SCC.
The Australian strains WA MRSA-18, -21 (both ST5) and -48
(ST835) represent a third group of CC5-MRSA-I. These strains,
however, harbour an atypical or truncated SCCmec I element. The
genes mecA, DmecR1, ugpQ and ccrB-1 are detectable; ccrA-1
occasionally yields a signal and pls-SCC is usually absent.
Resistance markers detected among these CC5-MRSA-I isolates
include the b-lactamase operon and, in some isolates, qacC
encoding resistance to quaternary ammonium compounds. In
addition to egc, the enterotoxin genes sed, sej and ser are associated
with these isolates as well as, variably, sea or sea-N315.
Figure 1. Overview of SCCmec elements, their variants and DNA microarray hybridisation patterns. Black circles, positive; grey circles,
present, but yielding weak or ambiguous signals; divided circles, variable genes.
doi:10.1371/journal.pone.0017936.g001
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ST5-MRSA-II is a pandemic CC5 strain. A MLST single locus
variant (SLV) of this strain, ST225-MRSA-II, has been reported
[45]. Different STs as well as a number of additional genetic
polymorphisms within this strain might suggest a polyphyletic
origin by multiple and independent transfers of SCCmec II
elements to various CC5-MSSA precursor strains [46]. Synonyms
and vernacular names are UK-EMRSA-3, New York-Japan
Clone, Rhine-Hesse Epidemic Strain, Irish AR07.3, Irish
AR07.4, Irish AR11, USA100 and Canadian MRSA-2 [28].
Published CC5 genome sequences of isolates belonging to this
strain include Mu3, Mu50, N315, JH1 and JH9. Isolates of ST5/
ST225-MRSA-II have been identified in Austria [38], Croatia
[41], Hong-Kong (China, [47]), Hungary [35], Japan [48],
Portugal [49], Taiwan [50], the UK and the USA [48]. The
authors have identified this strain in Ireland [15] and in different
regions of Germany, the UK, Hong Kong and Australia. In
Dresden/Saxony, ST5-MRSA-II is the second most prevalent
MRSA strain (accounting for approximately 30% of isolates), and
the most frequently isolated strain in this region’s intensive care
units [51]. Transmission of this strain has been reported in
Australia where the index case was shown to be a healthcare
worker who previously underwent surgery in a New York hospital
[52]. ST5-MRSA-II isolates usually exhibit spa types t002, t003 or,
in Ireland, t045. Antimicrobial resistance markers in ST5/ST225-
MRSA-II isolates may vary (see Figure 2), although erm(A) and the
aminoglycoside resistance gene aadD are commonly present.
Variable virulence-associated genes include tst1, sea, sea-N315,
sec, sed, sej, sel and ser [43]. Variants of this strain harbouring the
arginine catabolic mobile element (ACME) have been isolated in
Hong Kong and California/USA (NARSA 642).
CC5-MRSA-III has been isolated from humans in the South
African province of KwaZulu-Natal [53], from Korean chicken
meat samples [54], and from turkeys or turkey meat in Germany
(courtesy of S. Cortez de Ja¨ckel, Delbru¨ck, Germany, and of the
Federal Institute for Risk Assessment, Berlin, Germany). The latter
isolates harbour SCCmec IIIA, lacking tet(K) and the mercury
resistance operon. CC5-MRSA-III may initially appear to be
methicillin-susceptible but resistance is observed following growth
on selective agar containing methicillin [54].
CC5-MRSA-IV strains have achieved pandemic spread and
significant clinical relevance. Colloquially strains have been
described as the Paediatric Clone (although the first strain
described under that name HDE288 has been subsequently
shown to be CC5-MRSA-VI, [55]), WA MRSA-03 (ST5), -25
(ST575), -39 (ST526), -50 (ST73) and -74 (ST5), USA800 or
Marseille Cystic Fibrosis Clone (ST5; [56]). As for ST5/ST225-
MRSA-II, a large proportion of CC5-MRSA-IV isolates carry sea-
N315 and/or sed+sej+ser. Other virulence genes, including tst1 and
the epidermal cell differentiation inhibitor gene edinA, can be
found in a minority of isolates. A novel enterotoxin gene has
Figure 2. Resistance genes in MRSA strains.
doi:10.1371/journal.pone.0017936.g002
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recently been located on the same plasmid as edinA (GenBank
AP003089.1). Variable resistance markers in CC5-MRSA-IV are
shown in Figure 2.
PVL-positive CC5-MRSA-IV has been identified by the
authors in patients from the UK, France, Australia, Switzerland
and Senegal and previously in Ireland [57]. Based on toxin gene
profiles, these isolates cluster into three major variants harbouring
sea-N315+sed+sej+ser or sea+edinA, or edinA. Variable resistance
markers are shown in Figure 2.
ST5-MRSA-V has been described in Australia, where it is
colloquially known as WA MRSA-11, -14, -34 and -35, Ireland
[30] and Abu Dhabi. PVL-positive CC5-MRSA-V has been
identified sporadically in Germany and Abu Dhabi.
CC5-MRSA-VI was first observed in Portugal in 1992 [58]. It
was first described as Paediatric Clone carrying SCCmec IV but
was later reclassified as harbouring a SCCmec VI element [55]. In
France it was dubbed the New Paediatric Clone [44]. This strain
has been identified in Portugal, Colombia, Argentina and the USA
[58]. The authors identified New Paediatric Clone isolates (spa
type t105 or t777) in France, and very sporadically in Australia
and Germany, as well as PVL-positive CC5-MRSA-VI (spa t311)
in Switzerland. The latter strain has also been reported from the
Azores and Portugal [59].
A further novel SCCmec element (SCCmec type VII, [6] or
SCCmec JCSC6082, GenBank: AB373032.1) was recently de-
scribed in Sweden [16]. This strain (courtesy of C. Berglund,
Stockholm, Sweden) yields signals with probes for mecA, DmecR1,
ugpQ and ccrC, and it is positive for blaZ and tet(M).
In addition to the above mentioned strains, several CC5-MRSA
carry multiple or composite SCCmec elements. One of these strains
(ST149 which is a MLST single locus variant, SLV, of ST5, spa-
type t002) was recently described in Malta [40]. This strain carries
a SCCmec IV element as well as Q6GD50 and novel ccrA and ccrB
genes (GenBank GU066221). The latter are identical to
ccrASHP+ccrBSHP in a Chinese isolate of S. haemolyticus (GenBank
EU934095.1, [60]), where these genes were accompanied by the
ACME locus [61]. This locus, however, is absent in the Maltese
strain. It lacks PVL, but it carries sea, egc as well as, commonly, tst1,
sec and sel. Some isolates harbour the resistance genes erm(C) and
tet(K). This strain appears to be common in Malta [40], but has
not been reported elsewhere. Another, PVL- and tst1-positive
ST149-MRSA-IV has been isolated from a Libyan patient in
Switzerland [62].
A composite variant of a SCCmec IV has been described in the
CC5 strain MRSA-ZH47 [63]. It resembles a SCCmec IV element,
but also carries a set of SCCmec V-like recombinase genes (ccrC and
‘‘ccrAA’’, a putative recombinase gene, see Materials and Methods).
Another CC5 strain with multiple/composite SCCmec elements
originates from Spain. Isolates from a German patient hospitalised
in the Canary Islands [29] and from a patient in Barcelona
(Courtesy of S. Molinos, Barcelona) yielded hybridisation signals
for mecA, DmecR1, ugpQ, ccrA-2, ccrB-2, ccrA-4 and ccrB-4. Because of
Figure 3. Virulence-associated genes in MRSA strains (*, see text for further explanation).
doi:10.1371/journal.pone.0017936.g003
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the carriage of erm(C), msr(A), mph(C), aphA3 and sat as well as
affiliation to spa type t067, these isolates probably represent an
epidemic strain, or a close relative of it, recently described in Spain
[64]. Similar isolates harbouring only erm(C) have been found by
the authors in France, Australia and Germany.
A CC5 strain with a composite SCCmec element comprising
SCCmec IV, ccrA-1, ccrB-1 and Q6GD50 has recently been
described in the Netherlands [65].
Australian ST835 strains WA MRSA-40/46 harbour SCCmec
VT elements and ccrA/B-2 genes. These strains vary in the
presence of b-lactamase genes, the mupirocin and trimethoprim
resistance genes mupA and dfrA, qacA as well as of sed+sej+ser. The
authors have identified other CC5-MRSA which harbour
composite or multiple SCCmec elements including [mecA, DmecR1,
ugpQ, ccrA-1, ccrB-1, pls-SCC, dcs, ccrC], [mecA, DmecR1, ugpQ, dcs,
ccrA-2, ccrB-2, ccrC] and [mecA, ugpQ, ‘‘ccrAA’’, ccrC, ccrA-4, ccrB-4].
However, these MRSA strains were only represented by one or
two isolates in each case.
Sequence type 6
According to MLST data, ST6 is a double locus variant (DLV)
of ST5 (arcC-12 and yqiL-3 rather than arcC-1 and yqiL-10, as in
ST5). However, ST6 isolates differ in agr group, capsule and spa
types. They harbour different alleles of hsdS-, set/ssl- and several
MSCRAMM genes (bbp, fnbB, sdrC, sdrD, clfA, clfB, sasG). In
addition, isolates of this ST carry cna but lack egc. These
observations may be explained by a large scale chromosomal
replacement with one parental strain belonging to CC5. The
origin of the inserted region has not yet been determined. The size
and location of the insert can be estimated by analysing the known
positions of the probe sequences within the published CC5
genome sequences. Thus, the insert is localised around oriC, and
ranges from hsdS3 downstream of oriC to the ssl/set-locus upstream
of oriC. This equals ca. 1.500.000 bp (i.e., about half of the
genome). It can be assumed that the SCCmec element is integrated
into that insert. ST6 strains tested for the present study were PVL
negative. They included ST6-MRSA-IV from Australia (where it
is known as WA MRSA-51) and Abu Dhabi [31] as well as ST6-
MRSA-V from Hong Kong.
Clonal complex 7
CC7-MRSA are rare. One ST, ST1048, is discussed separately
due to its divergent hybridisation pattern.
The authors identified single isolates of CC7-MRSA-IV and
CC7-MRSA-V in Saxony and in Australia, respectively. The
enterotoxin A allele sea-N315, also known as sep, is present in both
isolates (and it is also common in CC7-MSSA). Both isolates are
PVL-negative.
Clonal complex 8
Similar to CC5, CC8 is a pandemic MRSA lineage. Numerous
MRSA strains have originated from CC8, including both CA- and
HA-MRSA, and several whole genome sequenced MRSA strains
represent this lineage (see Supplemental file S2). Although related
to CC8, ST72 and ST239/241 are discussed separately as they
exhibit distinct hybridisation patterns. The core genome genes of
the remaining CC8 strains such as protease, ssl/set and
MSCRAMM genes of clinical isolates are in accordance with
the sequenced genomes although occasional deletions of genes
such as bbp, clfA or sdrD can be observed. Carriage of exotoxins
and of b-haemolysin-converting phages is highly variable. Several
different CC8 strains have been described, and can be
distinguished based on SCCmec types and exotoxin profiles.
The first known MRSA was a CC8 strain, ST250-MRSA-I,
which is also known as Early or Ancestral MRSA, Irish AR02 or
Irish Phenotype I and II. The genome sequence (GenBank
CP000046) of the strain COL, which was isolated in England in
the 1960s, is representative of this strain [66]. The ST250-MRSA-
I clone seems to be disappearing. However, it is still isolated in
Australia, although rarely (one isolate out of more than 4000
tested, [67]). The description in this study is based on COL and on
isolates recovered from hospitalised patients in Ireland in the
1970s to 1980s [15]. All isolates closely resemble COL, and they
also show a characteristic deletion of several ssl/set genes. The
carriage of pls-SCC [15], several resistance markers (see Figure 2),
enterotoxin genes seb+sek+seq and of b-haemolysin-converting
phages (sak, chp and scn) is variable.
A very similar and, likewise, ancient strain is ST247-MRSA-I. A
reference isolate, NARSA 209, was recovered in the UK in 1971.
Vernacular names include North German Epidemic Strain, UK-
EMRSA-5, -8 and -17, Rome Clone, Spanish PFGE type E1, [34],
Irish AR22, Irish New02 and, after an outbreak in Barcelona in
1989, Iberian Clone [68]. ST247-MRSA-I seems to be receding,
as observed, for example, in Portugal [49] and Spain [69]. It has
not been identified in Dresden, Saxony, since 1997 ([70] and
authors’ observations) or in Ireland since 1999 [15]. Thus, the
description in this study is based partially on isolates recovered
from the 1990s. More recently, ST247-MRSA-I has been found in
Australia, Croatia [41], the Czech Republic [71], Italy, where it is
also becoming increasingly rare [33], and in the Netherlands
(isolates courtesy of P. Beisser, Maastricht). Although this strain
yields a hybridisation profile similar to that of ST250-MRSA-I, it
harbours a complete set of ssl/set genes, and with regard to these
genes it resembles the NCTC8325 or USA300 genome sequences
more than COL. Enterotoxin genes seb+sek+seq are rare, but about
half of the isolates harbour sea. As in other CC8 isolates, bbp is
deleted in a number of isolates. In addition to SCCmec I, all tested
isolates carry tet(M). Additional resistance markers have been
detected in some isolates (Figure 2).
Several different CC8-MRSA-IV strains have been described
previously based on different typing methods. In the following
paragraphs, we define these strains with reference to their carriage
of exotoxin genes. However, as these genes are located on mobile
elements such as phages or plasmids, it may be that these ‘‘strains’’
are in fact polyphyletic clusters. One of these strains includes CC8-
MRSA-IV isolates which lack PVL or any enterotoxin genes
(besides the ubiquitous enterotoxin homologue, GenBank
CP000046.1:SACOL1657). They belong to ST8 or ST576 (tpi-
19 instead of tpi-4) and include UK-EMRSA-14 and WA MRSA-
5, -6 and -31. NARSA 645 is a reference strain that shows an
Iberian Clone-like PFGE pattern (http://www.narsa.net). The
authors found only a single isolate from Germany. However, in
Australia this strain appears to be rather common. Isolates differ in
the carriage of b-haemolysin-converting phages and of a variety of
resistance genes.
Another PVL-negative CC8-MRSA-IV has been named the
Lyon Clone or UK-EMRSA-2. It is frequently isolated in France
[44], and can occasionally be identified in Germany, Ireland [30],
the UK, the Netherlands (isolates courtesy of P. Beisser,
Maastricht), Norway (courtesy of H. V. Aamont, Aakershus) and
Australia. Most isolates of this strain carry sea, sak and scn, as well
as, commonly, sed+sej+ser. Some isolates lack the sea gene. These
isolates harbour chp, sak and scn, or they have a non-disrupted hlb
gene and lack all IEC genes. Variable resistance markers are the
mercury resistance and b-lactamase operons, erm(A), erm(C), vga(A)-
BM3327, aacA-aphD, aadD, dfrA, far1, tet(K), tet(M), qacA and qacC.
Another related strain has been described as UK-EMRSA-6. It is
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also sea-positive, and differs from Lyon Clone/UK-EMRSA-2 in
the presence of aphA3+sat.
Another strain of CC8-MRSA-IV carries the enterotoxin genes
seb+sek+seq, but lacks PVL. It is known as USA500 with NARSA
385 being a reference strain. Isolates have been identified in the
USA (NARSA 119, -120, -121, -678, -686 and -708) and Australia
(as a SLV, ST612, WA MRSA-20, [72]) as well as, for the present
study, in the UK, in Ireland and, sporadically, in Germany. Some
of the German isolates were recovered from patients with travel
histories (Ethiopia, Zimbabwe and Mozambique) suggesting a
wide distribution of this strain in Sub-Saharan Africa. This is also
indicated by frequent observations of ST612 in South Africa [73].
USA500 has also been found in horses from the USA, Canada
[74], Ireland [30] and Germany [75] as well as from humans with
contact to horses [30]. Equine isolates differ from human isolates
of USA500 by the absence of lysogenic b-haemolysin converting
phages and thus they also lack the sea, sak, chp and scn genes. The
carriage of resistance markers is highly variable (Figure 2).
A notable PVL-positive ST8-MRSA-IV is the widely known
strain USA300 (also known as WA MRSA-12, Canadian MRSA-
10 [28] or Spanish PFGE type A, [34]). Within a few years it has
spread extensively across the USA, effectively marginalising other
S. aureus strains, MRSA as well as MSSA [76]. It is mainly
community-associated, but hospital-associated cases also occur
[77;78]. In Europe, USA300 has not been isolated frequently. For
instance, eight out of 25 PVL-positive CA-MRSA from Ireland
were identified as USA300 [57]. Since these isolates originated
from a sample of 1,389 MRSA isolates, it can be concluded that
USA300 in particular, and PVL-positive MRSA in general, are
much less of a problem in Ireland than in the USA [57]. In
Dresden/Saxony, the authors identified the first case of a USA300
infection in 2005 [29], but only sporadic isolates have subsequently
been observed (including three among 304 genotyped MRSA
isolates from patients of the University Hospital Dresden, 2007 to
2009, unpublished observation by the authors). In the UK,
USA300 is much less common than in the USA [79]. USA300 has
also been infrequently found in Switzerland [80] and Spain [81].
In Abu Dhabi, three out of 54 isolates were identified as USA300
[31]. In Australia, although the overall prevalence is low, case
numbers are steadily increasing [82]. Some infections with this
strain have also been noted in Japan [61] and Hong Kong (in the
present study). Two whole genome sequences of USA300 have
been published (USA300-FPR3757, GenBank CP000255, [61]
and USA300-TCH1516, GenBank CP000730, [83]). Both
sequences harbour SCCmec IV and adjacent ACME genes. It
has been hypothesised that this locus is related to enhanced
survival of the organism on intact skin and, thus, to increased
transmissibility by skin contact. However, a considerable propor-
tion of Australian USA300 isolates lack the ACME locus [82]. The
absence of ACME has been described in isolates from Colombia,
too [84]. Other genes or gene clusters are also subject to a high
degree of genetic variability in USA300 and genotyping of 76 West
Australian isolates identified 16 different variants of USA300 [82].
However, the most common variant in Germany, Abu Dhabi and
Australia is indistinguishable from the sequenced strain USA300-
TCH1516. Variability within USA300 can involve b-haemolysin
converting phages (sak, chp, scn) and enterotoxin genes (sek, seq). The
authors also observed isolates that yielded USA300-like hybrid-
isation patterns (including ACME), but lacked the SCCmec
element [82] or even the PVL genes (isolate courtesy of P. Beisser,
Maastricht), respectively. Resistance genes in USA300 are highly
variable (see Figure 2 and [82]). The recent detection of plasmid-
encoded cfr in an Irish USA300 isolate [21] is a reason for concern
as this gene confers resistance to five classes of antimicrobial drugs
including the oxazolidinones (linezolid).
Other CC8-MRSA-IV strains have been found sporadically in
Australia. One carries PVL and enterotoxin genes sed+sej+ser and
sek+seq, but lacks ACME (WA MRSA-62). Another harbours
tst1+sec+sel and, variably, edinA.
CC8-MRSA-V has been found occasionally in Saxony and
Australia. The Australian CC8-MRSA-V isolates (WA MRSA-53)
carry sea and seb+sek+seq. These genes, however, are absent in the
Saxon isolate.
CC8-MRSA-VIII harbouring a class A mec complex and ccrA/
B-4 genes has been recently described in Canada [17] where this
strain is known as Canadian MRSA-9. It was reported to carry
enterotoxin genes sea and seb. The authors obtained two isolates
(one from Ireland [85], and one from Australia, WA MRSA-16)
which were similar with regard to SCCmec associated genes.
However, they lacked the enterotoxin genes.
Several CC8-MRSA carry irregular, multiple or composite
SCCmec elements. One is ST8-MRSA-II also known as Irish
AR05, AR13, AR14, Irish-01 or Irish New03. This strain was
predominant in Ireland [86] in the 1990s. However, it now
appears to be marginalised by other strains. Thus, the following
description is based partially on isolates from the 1990s. It is spa
type t190. This strain harbours SCCmec II, from which the kdp
operon is absent [15]. Based on this observation as well as on
additional variation affecting the mec complex and the presence of
pUB110, carrying aadD, and Tn554, carrying erm(A), SCCmec II
subtypes A to E have been described [15]. Thus, the microarray
allows rapid SCCmec II subtyping with [aadD+ and mecI/xylR+]
being SCCmec IIA or IIB (depending on presence and localisation
of Tn554), [aadD+ and mecI/xylR-] being SCCmec IIC, [aadD- and
mecI/xylR+] being SCCmec IID and finally, [aadD- and mecI/xylR-]
being SCCmec IIE. Additionally, this strain harbours ccrA/B-4
genes, which are more homologous to those of the SCC-CI
element from S. epidermidis than to other ccrA/B-4 sequences from
MRSA [87]. The microarray revealed that the mercury resistance
operon is usually present, and a possible link to additional ccrA/B-4
genes, as seen in a SCC-CI element from S. epidermidis
(ATCC12228), is currently under investigation. Essentially all
ST8-MRSA-II, AR13/14 isolates harbour erm(A) and aacA-aphD.
Other resistance markers including blaZ+blaI+blaR and mupA are
variable. The majority of isolates carry a lysogenic b-haemolysin
converting phage (scn, sak, and sea). They do not harbour
enterotoxin genes apart from sea. Protease genes splA, splB and
splE as well as sdrC are usually absent.
Another strain with an irregular or composite SCCmec element
is ST8-MRSA-IV+ccrA/B-4, also known as Irish AR43, Irish-02,
UK-EMRSA-12 and -13. This strain predominated in Northern
Ireland in 1999 [86] (when most of the isolates described herein
were sampled), but it has also been found in Norway (isolates
courtesy of H. V. Aamont, Aakershus) as well as by the authors in
the UK and Australia. The spa type is usually t190 [87]. This strain
harbours SCCmec IV, although some isolates have been found to
lack ccrA/B-2, possibly due to in vitro passage or exposure to
freezing and thawing during storage. Variation in the region
downstream of the mec complex or, respectively, in the J1 and J3
regions, allowed distinguishing subtypes IVE and IVF [15].
Isolates of Irish AR43 harbour an additional set of ccrA/B-4 genes
similar to Irish AR13/14.
Irregular SCCmec elements can also be observed in ST254-
MRSA which is known as UK-EMRSA-10 or the Hannover
Epidemic strain (spa t009 or t036). Although in the 1990s ST254-
MRSA was frequently isolated in German hospitals, it has receded
since 2000. However, this strain is the predominant MRSA
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isolated from horses in Germany [75]. There are two variants of
this strain which differ in relation to the carriage of SCCmec
associated genes (see Figure 1). The Hannover Epidemic Strain is
a multi-resistant strain, and the antimicrobial resistance genes
tet(M) and aacA-aphD are always present. In addition, aphA3, sat as
well as the mercury resistance operon can be detected in most
isolates. The MSCRAMM gene bbp is usually absent. Enterotoxin
genes seb+sek+seq are always detectable. Genes associated with
lysogenic b-haemolysin-converting phages (sea, sak and scn) are
usually present in isolates from humans, but have not been
detected in equine isolates.
Clonal complex 9
Most CC9-MRSA strains have been recovered from veterinary
sources. Particular strains from humans, ST733/834, have been
assigned to CC9 by MLST, but will be discussed separately
because of their distinct hybridisation pattern. CC9-MRSA with
SCCmec types III and V have mainly been recovered from pigs or
farm workers in mainland China, Hong Kong and Malaysia as
well as in Italy [88-92]. The authors recently identified isolates of
CC9-MRSA-IV in turkeys (courtesy of S. Cortez de Ja¨ckel,
Delbru¨ck) and in retail chicken meat from Germany. Isolates are
PVL-negative and do not carry other enterotoxin genes besides egc.
Resistance markers are the b-lactamase operon, qacC, erm(B) and
aadD.
Clonal complex 12
An isolate of CC12-MRSA-IV genotyped for this study was
found in Ireland [15]. This strain was also observed in a small
number of cases in Norway [93]. Another CC12-MRSA strain,
WA MRSA-59 from Australia, has an irregular or truncated
SCCmec element (mecA, ugpQ, mecI, mecR1, but no xylR and no
detectable recombinase genes). Isolates carried the enterotoxin
homologue ORF CM14, sea-N315 and seb. PVL has not been
detected in this lineage.
Clonal complex 15
While CC15-MSSA are abundant among healthy carriers [94],
MRSA from this lineage are extremely rare. To our knowledge,
CC15-MRSA has only been detected in a collection of Italian
MRSA strains isolated in 1980. This included three SCCmec I
isolates and an isolate described to carry an SCCmec I variant in
which ccrA/B-1 was replaced by ccrA/B-2 [33]. Within the present
study, the authors did not identify a single CC15-MRSA isolate
among approximately 3,000 genotyped MRSA. Thus, the
description of the general features of this CC relies on data from
MSSA (Supplemental file S3, [94;95]). Exotoxin genes (lukF/S-PV,
sea, etA) are detectable only in a very small minority of isolates. The
chp and scn genes are present, but sak was absent from essentially all
isolates.
Clonal complex 20
A single isolate of a CC20-MRSA-V was identified in 2009 in
Australia. It is negative for PVL genes. It also lacks other toxin
genes, although seb, sec, sel and lukM+lukF-P83 genes have been
identified by the authors in CC20-MSSA of human and veterinary
origin.
Clonal complex 22
CC22 is a common and widespread clonal group and different
MRSA strains have emerged from this genetic background. The
sequencing of a complete genome of a CC22 strain could provide
valuable insight in S. aureus biodiversity since alleles from CC22
appear to differ from previously published sequences. For instance,
a CC22-specific allele of ssl7/set1 has already been identified
(GenBank AF188836). Many probes on the DNA array yield
irregular or weak signals with CC22 isolates, which could be
attributed to the presence of divergent sequences. Beside ssl/set-
and MSCRAMM genes, this also affects the c-haemolysin locus.
Probes for lukS/F-hlg and hlgA (derived from CC1, 5 and 8
sequences) yield weak or no signals, while a probe based on a lukS-
hlg sequence from CC45 is strongly reactive (GenBank EF672356)
[96]). Leukocidin lukD+lukE and proteases splA, splB and splE have
not been detected in CC22 isolates and it is not yet known whether
they may be present as variant alleles or are absent in this lineage.
CC22-MRSA with SCCmec types I, II or III have, to our
knowledge, not been reported.
ST22-MRSA-IV is a pandemic CC22-MRSA strain. This strain
is known as UK-EMRSA-15, Irish AR06, Barnim Epidemic
Strain or Spanish PFGE type E13, [34], or Canadian MRSA-8
[28]. It has been reported in many countries [33;57;97-104].
Where ST22-MRSA-IV occurs, it tends to be abundant. In
Dresden, ST22-MRSA-IV accounted for nearly 50% (141 out of
304 genotyped isolates from 2007 to 2009); in Portugal for 54%
[49], in Malta for 66% [40], and in Ireland [85;105] as well as on
the Azores [59] for more than 80% of MRSA isolates. In England,
ST22-MRSA-IV is increasingly common (apparently at the
expense of ST36-MRSA-II, UK-MRSA-16, [106]), being cur-
rently responsible for 85% of MRSA bacteraemia cases. ST22-
MRSA-IV occurs in hospitals as well as in outpatients, and it has
been recovered from animals such as horses [75], cats [107] and
dogs [102;107]. Common resistance markers are b-lactamase and
erm(C). A high percentage of Maltese ST22-MRSA-IV isolates
harbour Q6GD50 which has not been found in isolates from other
geographic regions [40]. Variable virulence markers in ST22-
MRSA-IV are sec and sel as well as the IEC genes encoded by
lysogenic b-haemolysin-converting phages (sak, chp, scn). The
presence of tst1, or sometimes of tst1 and sea, is found in some
isolates from Abu Dhabi [31], Egypt (isolates courtesy of M.
Kamal El Din, Cairo) and England (where patients’ names suggest
a Middle Eastern origin). A case of an infection with a tst1-positive
CC22-MRSA-IV has recently been reported from the USA, where
it was one of the first reports of this strain [108].
Another, distinct ST22-MRSA-IV strain is found in Dublin,
Ireland [109]. Its most distinguishing feature is the presence of the
ACME-locus. It carries b-lactamase and erm(C) as well as, in the
majority of cases, lnu(A), aacA-aphD, aadD and mupA.
A large scale nosocomial outbreak of PVL-positive ST22-
MRSA-IV has been described in Bavaria, Germany [110]. Other
isolates have also been found in Australia, England [111], Ireland
[57] Abu Dhabi [31] and Hong Kong. Additionally, PVL-positive
ST22-MRSA-IV has been isolated from patients in Germany who
had family ties to Turkey [112]. Their presence in epidemiolog-
ically unrelated settings suggested a polyphyletic origin, given that
PVL-positive CC22-MSSA are common and widespread [113].
Indeed, the demonstration of at least three different PVL-encoding
phages, QPVL, Q108PVL and an unidentified icosahedral phage,
in CC22-MRSA from England and Wales [40] indicates that this
‘‘strain’’ has evolved on multiple occasions. Furthermore, ST22-
MRSA-IV harbouring PVL and tst1 genes have been recently
described in India [114]. Variable resistance markers in PVL-
positive ST22-MRSA-IV include b-lactamase, erm(C), aacA-aphD,
aadD, dfrA and Q6GD50.
Sporadic cases of a PVL-negative CC22-MRSA-V have been
identified by the authors in Saxony, as well as a PVL-positive
CC22-MRSA-V in Western Australia.
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Clonal complex 30
CC30 is another important clonal complex from which HA-
and CA-MRSA originate. It is represented by the genome
sequence of Sanger MRSA 252. Core genomic markers, ssl/set-
and MSCRAMM genes are present as allelic variants which differ
distinctly from other CCs. Some of these variants resemble alleles
found in other CCs such as CC22 and CC45 [96] which may be
more closely related to CC30 than to other CCs such as CC1,
CC5 or CC8 [115]. Shared features of CC30 strains include the
presence of egc (although partial deletions may occur) and cna.
MSCRAMM genes bbp, fnbB and sdrD are usually detectable, but
may be deleted from individual isolates. Lysogenic b-haemolysin-
converting phages are usually commonly present. Because of the
variable presence of sea and chp, it can be assumed that different
phages have integrated into CC30 genomes.
CC30-MRSA-I was reported in Italy in 1980 [33].
A more widespread HA-MRSA strain from this lineage is
ST36/39-MRSA-II, also known as UK-EMRSA-16 [116],
USA200, Irish AR7.0/AR07.2, Spanish PFGE type E12, [34],
or Canadian MRSA-4 [28]. Although frequently isolated in the
UK and Ireland in the 1990s [15], recently it has become
increasingly rare [107]. Isolates have also been found in Malta
[40;117] and South Africa [73]. In Germany, ST36-MRSA-II is
very rare. This strain harbours SCCmec II including aadD and
erm(A) in integrated pUB110 and Tn554, respectively, as well as
the b-lactamase operon and occasional other resistance markers
(Figure 2). Most clinical isolates carry tst1, although this gene is
absent in the genome sequence of Sanger MRSA252. This strain
also lacks sdrD. The enterotoxin gene sea is also common, although
another reference strain, ATCC43300, is sea-negative.
ATCC43300 is unique among the tested ST36/39-MRSA-II in
being positive for sec+sel and fnbB.
Another important CC30-MRSA strain is the PVL-positive
ST30-MRSA-IV, Southwest Pacific Clone, USA1100 or West
Samoan Phage Pattern (WSPP) Clone. This CA-MRSA strain was
first observed among Samoan immigrants in New Zealand, but is
widespread with isolates investigated in the present study coming
from Germany, Switzerland, the UK, Australia [29;80], Hong
Kong, Taiwan [50], Abu Dhabi, and the USA (NARSA 484).
Other reports of this strain include Ireland [57], where it is the
predominant PVL-positive MRSA strain, Scandinavia, Latvia
[118] and Kuwait [119]. The WSPP Clone apparently evolved
from the pandemic phage type 80/81 strain. This MSSA emerged
in the 1950s and caused outbreaks of severe infections worldwide;
however it virtually disappeared after the introduction of
penicillinase-resistant b-lactams [120].
A PVL-negative, but tst1-positive strain of ST30-MRSA-IV is
sporadically isolated in Ireland [15] and Australia. An infection
with a PVL-positive CC30-MRSA-V has been described in Egypt
[121]. A similar isolate has been identified from a patient with a
SSTI living in the German/Polish border region (courtesy of R.
Hillert, Go¨rlitz).
Clonal complex 45
CC45 is another major lineage from which several MRSA
strains have emerged. They cluster into two distinct groups as the
majority of isolates belong to agr group I, while some strains yield a
unique pattern. They fail to react with all three agrD-I probes, but
they are positive with agrB and agrC probes corresponding to agr
groups I and IV (for the sake of simplicity they are here referred to
as CC45/agr IV). PVL has not been detected in the present study
among CC45-MRSA isolates. However, two cases of PVL-positive
ST45-MRSA-IV from Belgium [45] and Germany [122] have
been reported. Leukocidin genes lukD+lukE were not identified. In
contrast to CC22, the c-haemolysin genes hlgA and lukF-hlg can be
detected in CC45 isolates, and lukS-hlg was shown to be present in
a specific allelic variant (GenBank EF672356, [96]). As observed in
CC22, probes for protease genes do not yield signals. Enterotoxins
sec and sel are occasionally found. Irregular signals for ssl/set might
indicate the presence of yet unknown alleles. The gene cna is
present, but sasG can only be detected in the CC45/agr IV isolates.
ST45-MRSA-II, (known as USA600, USA600-MRSA-II or
Canadian MRSA-1 [28]) appears to be largely restricted to North
America, where glycopeptide-resistant variants and an unusually
high mortality rate of bloodstream infections associated with this
strain have been reported [123]. Outside the USA, ST45-MRSA-
II is rarely isolated, but this strain has, like ST45-MRSA-I and -III,
been sporadically detected in Hong Kong [47]. In addition, the
authors have identified a single isolate of ST45-MRSA-II in
Australia. This isolate as well as reference strains NARSA 22,
NARSA 648 and NARSA 715 were genotyped. They carry
SCCmec II, including aadD and erm(A), as well as the b-lactamase
operon. Variable resistance markers (positive in NARSA 22)
include aacA-aphD, dfrA and qacC.
Another important CC45 strain is ST45-MRSA-IV, which is
known as the Berlin Epidemic Strain, WA MRSA-75 or USA600-
MRSA-IV. In Saxony, it is a relatively common MRSA strain (ca.
9% of MRSA isolates from Dresden, 2007-2009), and in Belgium
it is the predominant MRSA strain [45]. This strain also occurs in
the UK, the Netherlands [45], Switzerland [124], Croatia [41]
and Australia. Unlike the Australian isolates, most of the Saxon
isolates harbour aphA3 and sat. As in other CC45 strains, egc is
present but seg is not detectable in many isolates. Enterotoxin
genes sec and sel as well as genes sak, chp and scn, indicative
of lysogenic b-haemolysin-converting phages, are commonly
detected.
A similar CC45-MRSA-IV strain isolated in Australia carries
sec, sel, tst1 and ACME.
ST45-MRSA-V has been found sporadically in Germany and in
Australia (WA MRSA-4) as well as in Portugal [49]. Most isolates
tested for this study harbour tst1, sek and seq.
A distinct group of CC45 isolates display agr IV alleles.
Furthermore, these strains differ from other CC45 strains in that
they carry other alleles of MSCRAMM genes fnbA, fnbB, sdrD, vwb
and of lmrP. They are positive for sasG. Isolates carry sej and
usually yield weak signals for ser probes, which may indicate the
presence of an allelic variant of this gene. The gene sed, which is
normally located on the same plasmids as sej and ser (e.g., pIB485,
GenBank M94872.1) cannot be detected. The spa types associated
with CC45/agr IV isolates are t727, t1081 (although this type can
also be observed in ST1048 and ST1774, see below and [125]) or
t1575. CC45/agr IV MRSA are widespread and increasingly
common in Australia. There are two different strains carrying
SCCmec type IV (WA MRSA-23) or V elements (WA MRSA-84),
respectively. CC45/agr IV-MRSA-IV and -V are commonly
isolated in Hong Kong (author’s observations, [47;125]) and few
isolates of a CC45/agr IV-MRSA with a combined SCCmec IV/V
element have been identified as part of this study in Hong Kong.
One of these isolates is ACME-positive. Sporadic isolates of
CC45/agr IV-MRSA-IV have also been observed in Ireland [15].
Clonal complex 59
Several strains of CC59-MRSA can be distinguished based on
carriage of SCCmec elements and PVL as well as on MLST and spa
typing. West Australian strains of CC59 have recently been
described in detail [126].
One PVL-positive strain, ST59-MRSA-IV, also known as
USA1000, is mainly restricted to the USA (reference strains
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NARSA 483, NARSA 676). The authors identified a single isolate
of USA1000 from Australia. The spa types associated with this
strain are t216 or t316. USA1000 carries the b-lactamase operon
and, variably, erm(A). Beside PVL, it harbours chp, scn and,
variably, the enterotoxin genes seb, sek and seq. A sporadic
Australian strain (WA MRSA-73, spa t528) is PVL-negative, but
otherwise indistinguishable from USA1000 in terms of overall
hybridisation patterns.
WA MRSA-24 is an infrequently isolated, mainly Australian
CC59 strain with a SCCmec IV element. This strain belongs to
ST87 (a SLV of ST59) and spa type t216. The b-lactamase operon,
msr(A), mph(C), aphA3+sat, seb, sek and seq are present. This strain is
also positive for sak, chp and scn but lacks sea. PVL is absent.
A group of sporadic Australian, Hong Kong and UK [127]
isolates, dubbed WA MRSA-55/56, are ST59-MRSA-IV/spa type
t437. These isolates carry PVL (although one PVL-negative isolate
was also identified), seb, sek and seq. The gene sea is only detected
occasionally.
The most widespread CC59-MRSA strain is PVL-positive
ST59/952-MRSA-VT which is known as the Taiwan Clone.
Isolates of this strain belong to spa types t437, t1950 or t2365.
ST59/952-MRSA-VT is a common and clinically important
MRSA strain in Taiwan [14;128-131]. The authors found this
strain in Hong Kong, Australia, where it is the most frequently
isolated CC59-MRSA strain, Saxony (a single case of recurrent
furunculosis, [29]) and the UK [127]. This strain has a
characteristic variant of a SCCmec V element, in which two ccrC
genes are present (SCCmec VT or 5C2&5, GenBank AB12129,
[132]). Enterotoxin genes seb+sek+seq are usually detectable. All
isolates carry erm(B), aphA3+sat and blaZ+blaI+blaR. In addition,
tet(K) and cat can often be found. This strain is indistinguishable
from WA MRSA-55/56 in all markers covered by the microarray
with the sole exception of the SCCmec element. Therefore, it may
be assumed that both strains emerged from the same ancestral
MSSA acquiring different SCCmec elements.
Additionally, there are also ST59-MRSA isolates harbouring a
SCCmec V rather than a SCCmec VT element. PVL-negative
ST59-MRSA-V (WA MRSA-9) has occasionally been observed in
Australia [126] as well as PVL-positive CC59/ST359-MRSA-V in
the UK [80].
WA MRSA-15 is another ST59 strain with a composite or novel
SCCmec element. This is the second most common CC59-MRSA
strain in Australia [126]. Its spa type is t976. Microarray
hybridisation and PCR results suggest either the presence of a
composite IV and V SCCmec element, or the presence of ccrC in
addition to SCCmec IV. This strain is PVL-negative, but it
harbours sea and usually seb+sek+seq. The b-lactamase operon is
present while msr(A)+mph(C), aphA3+sat and tet(K) can be detected
sporadically.
Sequence type 72
According to the MLST database, ST72 belongs to CC8.
However, isolates yield a distinctive hybridisation profile. Differ-
ences to CC8 include the presence of egc and of CC5-like alleles of
several MSCRAMM genes (bbp, sdrC, sdrD). MLST suggests a
recombination of CC5 and CC8. Specifically, yqiL, pta and tpi may
be derived from CC8 (yqiL-3, pta-4, tpi-4), while gmk, aroE and arcC
suggest CC5 parentage (gmk-8, aroE-4, arcC-1). The glpF allele (glpF-
1) may have originated from either clonal complex. Mapping the
positions of probe binding sites over the known CC5 and CC8
genomes shows that CC5- and CC8-derived genes alternate
through the genome suggesting multiple recombination events.
Alleles of some ssl/set genes and vwB, sasG and clfB which are not
associated with CC5 or CC8 suggest the involvement of
additional, yet unidentified donor strains.
Two MRSA strains have been identified. One is a PVL-negative
ST72-MRSA-IV which is known as USA700. It does not harbour
exotoxins beside egc, and its carriage of resistance genes is variable
(Figure 2). This strain includes NARSA 386 and 689. Isolates have
been identified in Saxony and in Abu Dhabi. PVL-positive ST72-
MRSA-IV has been isolated by the authors in Australia (WA
MRSA-44) and from SSTIs of German tourists returning from
Costa Rica.
Clonal complex 75, sequence types 883 and 1303
CC75 (ST75, ST1304) as well as ST883 and ST1303 are
discussed as a group because they share several distinctive features.
ST75-MRSA-IV (WA MRSA-8 and -79) isolates have been
recovered from people residing in remote communities of
Northern and Western Australia, and appear to be largely
restricted to this part of the world. Although it is PVL-negative,
this strain is a common cause of community acquired SSTIs [133].
There has been a single report of ST75-MRSA-V [133]. One
isolate of ST1304-MRSA-IV (WA MRSA-72) from Australia was
characterised. This is a SLV of ST75-MRSA-IV that also differs in
carriage of possibly plasmid-borne enterotoxin genes (see below).
ST883-MRSA-IV (WA MRSA-47) and ST1303-MRSA-IV occur
sporadically in the Northern part of Western Australia.
Recently it has been shown that MLST genes of these strains
differ grossly from that of any other known S. aureus (see [134] and
Figure 4). Although not phenotypically different to other S. aureus,
it has been suggested that ST75 strains should be regarded as a
new subspecies of S. aureus [134]. These strains do not yield
hybridisation signals with specific probes for capsule types 1, 5 or 8
and for agr groups I to IV. Unique agrB, agrD and agrC sequences
have been demonstrated in ST75 (GenBank FJ154839, [135;136])
and ST883 (GenBank HQ260328, [136]). Genes encoding
leukocidins and exfoliative toxins as well as protease genes splA,
splB and splE cannot be detected by microarray hybridisation.
Probes for MSCRAMM-, ssl/set- and hsdS-genes generally yield
patterns which differ from all other S. aureus strains. With regard to
these genes, ST883 and ST1303 resemble each other but differ
from CC75. The gene cna is absent and sasG can be detected in
CC75 only. The b-haemolysin gene hlb can only be detected when
using random primer directed amplification, suggesting the
presence of an allelic variant. CC75 and ST1303 carry egc
(although sen is either absent, or present in an unknown allele).
Seven out of eighteen ST75-MRSA-IV isolates as well as the single
ST1303-MRSA-IV isolate tested carry seb. ST1304-MRSA-IV is
positive for sed+sej+ser.
Clonal complex 80
The vast majority of CC80 isolates belong to a PVL-positive
strain harbouring SCCmec IV. Although SCCmec type I has
previously been described in CC80 [41], the authors did not
identify this strain in this study. Likewise, PVL-negative variants of
CC80-MRSA-IV are infrequently isolated and have only been
found in France and Croatia [41].
PVL-positive CC80-MRSA-IV has been dubbed the European
CA-MRSA Clone. The strain is widespread and has been isolated
in Austria [137], Denmark (where this strain was detected as early
as 1993 [138]), France [44], Germany [80;139], Greece (isolates
courtesy of V. Gogou, Larissa, [48;140]), Ireland [57], Malta [40],
the Netherlands [141], Norway [93], Portugal [142], Sweden
[143], Switzerland [80] and the UK [80;144;145]. In Greece, a
considerable percentage of MRSA infections can be attributed to
this strain [140]. The authors have identified isolates in Abu
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Dhabi, and other studies also indicate a wide distribution in the
Middle East including Kuwait [119], Lebanon [146], Israel [39],
Egypt [147] Algeria [148] and Tunisia [149]. Travellers returning
from the Dead Sea or from Saudi Arabia to Germany [112], or
from Tunisia or Libya to Switzerland [62] as well as patients with
family ties to Turkey [112] have been found to carry this strain. In
Australia, ST80-MRSA-IV as well as two SLVs, ST583 (WA
MRSA-17) and ST728 (WA MRSA-30) are rarely isolated. CC80-
MRSA-IV carries PVL, etD and edinC, but lack enterotoxin genes
(beside an ubiquitous homologue, GenBank CP000046.1:SA-
COL1657). Nearly all CC80-MRSA-IV isolates carry aphA3 and
sat; and they harbour the plasmid encoded genes blaZ, tet(K) and
far1. Additional resistance genes lnu(A) or erm(C) are rarely
detected. Mupirocin resistance in this strain has been reported
previously [150].
Clonal complex 88
Several different CA-MRSA belong to this CC which appears,
based on spa sequences and hybridisation profile, closely related to
CC1 and CC80. It includes ST78-MRSA-IV (as well as its SLVs
ST129, ST255, ST257), which is known in Australia as WA
MRSA-2. This strain is PVL-negative, but usually harbours
enterotoxin genes sec and sel. In addition, the vast majority of
isolates carry blaZ and erm(A). It is frequently isolated in Australia,
and a single isolate has been identified, as part of this study, in a
patient from Saxony.
CC88-MRSA-IV carrying the exfoliative toxin gene etA were
identified by the authors in the Netherlands, Portugal, Angola and
Senegal. There is also a report from Japan [151]. PVL-positive
CC88-MRSA-IV has been identified by the authors in the UK
[80], Abu Dhabi and Australia. Other reports of this strain have
come from Spain [152] and Nigeria [153].
PVL-positive CC88-MRSA-V and PVL-negative CC88-
MRSA-VI have been identified sporadically by the authors in
Western Australia. PVL-positive CC88-MRSA-V were recently
described from Italy [33; 154].
Sequence type 93
ST93 is a unique ST of S. aureus, which is essentially restricted to
Australia. While PVL-negative ST93-MRSA-IV and PVL-positive
ST93-MRSA-VT are extremely rare, a PVL-positive ST93-
MRSA-IV is common and currently spreading across Australia
[155]. This CA-MRSA strain is also known as the Queensland
Clone [156]. A few cases have been identified in the UK
suggesting small scale importation due to travel activities [157].
Recently, a whole genome sequence, JKD6159 (GenBank
CP002114), has been released. In terms of hybridisation profiles
and especially with regard to ssl/set genes, ST93 differs markedly
Figure 4. Network graph visualising relationships between concatenated MLST sequences of all STs mentioned in this study.
doi:10.1371/journal.pone.0017936.g004
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from other S. aureus lineages [80]. Enterotoxin genes and tst1 are
absent but the enterotoxin homologue ORF CM14 is present.
Clonal complex 97
CC97-MSSA can often be isolated from cattle [158] and
occasionally from humans [95], but MRSA from this lineage are
rare. CC97-MRSA-IV has sporadically been isolated from human
patients in Australia (WA MRSA-54), Abu Dhabi [31] and, as part
of this study, in Saxony. A ST97-MRSA-V has been isolated in
Egypt (isolate courtesy of M. Kamal El Din, Cairo). A further
CC97-MRSA strain has recently been described from the UK
[159;160], in which a SCCmec V element, ACME and ccrA/B-4
genes are detectable. A CC97-MRSA strain was identified by the
authors in swine from Germany. The strain carries a novel or
composite/hybrid SCCmec element yielding signals with probes for
mecA, ugpQ, ccrA-1, ccrB-1, ‘‘ccrAA’’ and ccrC. All CC97-MRSA
isolates tested are PVL-negative.
Clonal complex 121
Although CC121-MSSA are a common cause of SSTI worldwide
[113;142;153;161;162], MRSA from this lineage appear to be very
rare. The authors found a single MRSA isolate, CC121/ST577-
MRSA-V (WA MRSA-22), in Australia. While PVL is common in
CC121-MSSA [113], this isolate is PVL-negative. It harbours etA
and edinA. Further CC121-MRSA-IV have been described from
sporadic cases in the UK [145], Portugal [163], Poland (http://
www.isssi2008.com/abstract/13.asp), China (see MLST database,
quoted in [163]) and the USA [164]. A PVL-positive CC121-
MRSA-V strain was identified recently in two unrelated paediatric
patients from Cambodia [165].
Clonal complex 152
CC152-MRSA-V has been found sporadically in Germany
[80], Sweden [166], Switzerland [62] and Australia (WA MRSA-
89). Some patients infected with this strain had ties to Balkan
countries (Macedonia, Kosovo [62;80]) which might indicate a
wider distribution in that region. All isolates of this strain carry
PVL genes and edinB. Probes for lukD+lukE as well as hlgA+lukS-
hlg+lukF-hlg yield signals only after random amplification, which
suggests the presence of hitherto unknown alleles. Enterotoxin
genes and most ssl/set genes are not detectable.
ST377-MRSA-V has been observed in France, the Netherlands,
Switzerland and Australia [167]. It is closely related to ST152 and
cannot be distinguished using standard MLST primers. Specific
gmk primers able to distinguish ST152 from ST377 have been
described by Garnier [167]. A ST152-MRSA with a non-typeable
SCCmec element has been isolated in Denmark from a patient with
a travel history to Kosovo [138].
Sequence type 154
Two ST154-MRSA isolates have been characterised in this
study, both cultured from central Asian immigrants to Western
Europe [57;166]. The origin of these two isolates as well as a
report from Mongolia [168] suggests a wide distribution of this
strain in Central Asia. One isolate harbours a typical SCCmec IV
element, while the other (courtesy of C. Berglund, Stockholm)
lacks ccrA-2 and ccrB-2. Both isolates are PVL-positive.
Clonal complex 188
According to MLST data, CC188 is related to CC1 although it
differs in two alleles (arcC-3 and gmk-8 instead of arcC-1 and gmk-1
[169]). However, CC188 hybridisation profiles are clearly distinct.
Differences include the alleles of the agr locus, clfA, clfB, ebh, ebpS,
fnbA, fnbB, hsdS, sdrC, sdrD and vwb, the presence of cna as well as
the absence of sasG, seh, splA and Q2FXC0. Since these genes are
distributed widely across the genome, the differences to CC1
strains cannot readily be explained by chromosomal replacement
as previously observed for ST34 and ST239 [170]. Therefore,
either the positions of the genes in the genome may be different
than in the sequenced genomes, or CC188 originates from
multiple recombination events.
ST188-MRSA-IV has been found sporadically in Australia (WA
MRSA-38 or -78, [72]). Apart from SCCmec IV, b-lactamase and
aacA-aphD, this strain may carry erm(B), tet(K) and cat. PVL,
enterotoxin genes and tst1 are not present. Other ST188-MRSA
have been observed from Asian countries: ST188-MRSA-III/spa
t189 in Korea [171], PVL-negative CC188-MRSA-V in Hong
Kong, and PVL-positive ST188-MRSA-V in Malaysia [172].
Sequence type 239
ST239 isolates belong to CC8. However, ST239 (including
ST240 and ST241, which differ only in mutations in pta or yqiL
genes, respectively) is discussed separately from CC8. The reason
is the integration of a CC30 DNA fragment of approximately
635,000 base pairs (or ca. 20% of the genome, [170;173]) into a
CC8 parent strain, with the integration site being localised around
oriC. This has led to divergent MLST profiles (arcC-2, rather than
arcC-3, [170;173]), spa types and hybridisation profiles. Differences
to other CC8 strains include the affiliation to capsule type 5, the
alleles of aur, clfB and isaB and the presence of cna, while other
markers (such as agr group I alleles, ssl/set genes etc.) are in
accordance to CC8. Two genome sequences of ST239-MRSA-III
have recently been released (strain TW20, [173] and JKD6008,
[174]).
ST239-MRSA-III is probably the oldest pandemic MRSA
strain. It has been reported in many European countries including
Croatia [41] the Czech Republic [71;175], Greece (isolates
courtesy of V. Gogou, Larissa), Italy [33], Malta [40], Portugal
[49;176], Spain [69] and the UK. In Hungary, it was common but
it has been largely replaced by ST228-MRSA-I [35]. In Ireland,
ST239-MRSA-III became the predominant strain in the 1980s
[15], after it was introduced into the country following the
repatriation from Iraq of a trauma patient [177]. In Saxony, this
strain is rarely isolated and has been identified by the authors in
patients with travel histories to Greece [29] or Turkey. This strain
is frequently isolated in Turkey [178], Iran [179], Saudi Arabia
[180], Hong Kong [47], mainland China [181;182], Taiwan
[14;181] and Singapore [183]. In Trinidad & Tobago [184] it is
virtually the only existent MRSA. In Australia, it is a common
cause of hospital-acquired infection in the East coast states, and
large outbreaks in the 1980s were attributable to this strain [155].
Furthermore, ST239-MRSA-III has also been reported in
Argentina [185], Brazil [186;187], Chile [185], Egypt (isolates
courtesy of M. Kamal El Din, Cairo), India [104], Korea [171],
Malaysia [172], Mongolia [168], New Zealand [174], Pakistan
[188], Paraguay [42], Russia [189], South Africa [73], Thailand
[176] and Uruguay [185]. The reference strain ATCC33592,
recovered in a hospital in New York [190], belongs also to ST239-
MRSA-III.
The evolution of this strain has recently been reviewed based on
genome sequences of 63 isolates from different parts of the world
analysing genome-wide single-nucleotide polymorphisms, inser-
tions or deletions [191]. In short, ST239-MRSA-III can be divided
into three clades; a European, presumably ancestral one, an Asian
and a South-American. However, there is some evidence for
secondary, travel-associated cross-transmission [191].
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ST239-MRSA-III is colloquially known as the Czech, Vienna,
Hungarian, Portuguese or Brazilian Clone, UK-EMRSA-1, -4, -7,
-9 or -11, AUS-EMRSA-2 or -3, Irish Phenotype III, Irish AR01,
-09, -15 or -23, Canadian MRSA-3 (this refers to the ST241 SLV,
[28]) or as Canadian MRSA-6 [28]. However, all these
designations should be regarded as synonyms as their distinction
is not always clear-cut. For instance, the Hungarian Clone was
described as harbouring SCCmec III, while the Brazilian Clone
carries SCCmec IIIA [192]. The difference is only the presence (III)
or absence (IIIA) of an integrated plasmid pT181, which
encompasses, among other genes, tet(K). Since the SCCmec-
associated mercury resistance operon and other resistance and
enterotoxin genes vary independently of pT181/tet(K) among
these clones and since tet(K) might also be part of free plasmids,
tet(K) could be regarded just as one mobile element among many
others. Beyond the issue of tet(K), there are also other variations of
the SCCmec III element. About two thirds of tested isolates
harbour the mercury resistance operon. It is often, but not always,
accompanied by ‘‘ccrAA’’+ccrC. This indicates a linkage of SCCmec
III to SCCmer [4]. Some isolates do not yield signals with a probe
which normally reacts in both, mecR1 and DmecR1; this could
probably be attributed to another partial deletion of the mecR1
gene. In one case, the authors found the absence of mecI, mecR1
and xylR. Variable resistance genes in ST239-MRSA-III include
erm(A), erm(C), aacA-aphD, aadD, aphA3, sat, dfrA, mupA, tet(K),
different alleles of cat, qacA and qacC. PVL has not been detected in
ST239-MRSA-III. Enterotoxin genes sea, sek and seq as well as
phage-associated genes sak, scn and chp are variable. The ACME
locus is present in a minority of isolates ([172], and in three out of
some 200 tested by the authors).
Clonal complex 361
The authors observed three different CC361-MRSA strains. All
are PVL-negative. CC361-MRSA-IV is detected sporadically in
Western Australia (ST672-MRSA-IV or WA MRSA-29, [72]) and
one isolate originated from Ireland. CC361-MRSA-V was isolated
in Abu Dhabi where it appears to be rare [31]. A CC361-MRSA-
VIII was found in Australia where it is referred to as WA MRSA-
28 [72]. Isolates harbour the enterotoxin gene locus egc, which,
however, might be partially deleted. One out of three tested WA
MRSA-29 isolates carries tst1 and seb, which is a highly unusual
combination of virulence genes [193].
Clonal complex 398
CC398-MRSA has recently received a lot of attention as strains
from this lineage are of animal origin but are able to cause disease
in humans. This has led to intense investigations including the
sequencing of a complete genome of a ST398-MRSA-V strain,
S0385, from the Netherlands [194].
ST398-MRSA-III, spa type t567, has been observed in
Belgium [13]. ST398-MRSA-IV isolates appear to be a rare
livestock-associated MRSA (LA-MRSA) strain. Two infections
of humans were observed in Hong-Kong [47] and isolates from
poultry have been reported from Belgium [13]. In Germany,
this strain has been detected in cattle [195] and in turkeys
(courtesy of S. Cortez de Ja¨ckel, Delbru¨ck), and by the authors
in turkey meat samples. Isolates are negative for exotoxin genes
and for sak, scn and chp.
PVL-negative ST398-MRSA-V is frequently found in association
with livestock, although this strain is also increasingly isolated from
human patients without animal contact. It was first discovered in a
family outbreak in the Netherlands in 2006. Family members were
farmers, and the strain was subsequently found in pigs from the
same farm. Further investigations showed its presence in a high
proportion of Dutch pigs as well as in farm personnel, veterinarians
and students [196-200]. Recently, this strain has been observed not
only in pigs, but in humans, cattle [158;195], horses [75], dogs
[201], poultry [13], chickens and turkeys (courtesy of S. Cortez de
Ja¨ckel, Delbru¨ck and of the Federal Institute for Risk Assessment,
Berlin). It was also found in retail meat of different domestic animals
[202;203]. In addition to the Netherlands, ST398-MRSA-V has
been identified in Germany, Belgium, Italy, Austria, Spain
[13;90;202;204-208] Canada (http://promedmail.oracle.com/
pls/otn/f?p= 2400:1001:8447806422203976::NO::F2400_P1001_
BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1010,81749), the
USA [209] and Australia (author’s unpublished observation). This
strain shows a remarkable diversity with regard to resistance genes.
Isolates carry SCCmec V, or rather SCCmec VT, as indicated by the
genome sequence of strain S0385 [194]. Rarely, recombinase genes
‘‘ccrAA’’ and ccrC may be absent. Essentially all isolates harbour the
b-lactamase operon and tet(M). Additionally, tet(K) is frequently
detected. The multidrug resistance gene cfr has recently been
observed in ST398-MRSA-V [19]. In addition to the resistance
markers detected by array hybridisation (Figure 2), tet(L), dfrK and
dfrG can be found by PCR in some isolates [210–212]. Recently, the
novel trimethoprim resistance gene dfrK [210], the macrolide-
lincosamide-streptogramin B resistance gene erm(T) [212], a ABC
transporter gene vga(C) for streptgramin A-lincosamide-pleuromu-
tilin resistance ([213]) and the novel apramycin resistance gene apmA
[214] have been described on plasmids from this strain. Many
isolates of ST398-MRSA-V harbour multiple resistance genes
which provide the same resistance phenotypes (tet(K)+tet(M),
tet(L)+tet(M) or tet(K)+tet(L)+tet(M); erm(A)+erm(C) or erm(A)+erm(B)).
The vast majority of ST398-MRSA-V isolates are negative for
enterotoxin genes. Among 54 swine isolates from Germany, seb was
detected only once, and sek+seq were detected in three isolates [215].
The genes sak, scn and chp were absent from isolates of the European
LA-MRSA strain. However, these genes where detected by the
authors in two human isolates from Hong Kong; one of which
harbours sea.
PVL-positive ST398-MRSA-V has been described in China
[216], and in children of Asian origin living in Sweden [217]. Two
isolates (courtesy of C. Welinder-Olsson, Gothenburg, Sweden)
have been genotyped. In contrast to the livestock-associated
ST398-MRSA-V isolates, they carry sak, scn and chp. One isolate
harbours also sea.
Sequence type 426
ST426-MRSA-IV has recently been described from the
Arkhangelsk region in Russia [162]. The authors did not isolate
ST426-MRSA within the present study, but genotyping data of
ST426-MSSA isolates [94;95;113] allow the general features of
that sequence type to be described. ST426-MSSA isolates
harbour tst1, sea and ORF CM14 as well as, variably sec+sel, see
and/or sek+seq. The gene cna can be detected in most isolates.
Notably, nuc (encoding thermostable nuclease, DNAse) is not
detectable by hybridisation. Since ST426 isolates are phenotyp-
ically DNAse-positive, the presence of a variant nuc allele can be
assumed.
Clonal complex 509
CC509 appears to be a very rare CC [94;218], but MRSA
belonging to it have previously been observed in Queensland,
Australia [218]. One isolate of CC509/ST207-MRSA-V from
New South Wales, Australia was genotyped. It is PVL-negative.
The egc locus appears to be present in a variant or truncated form
with only genes sem and seo being detectable.
A Field Guide to MRSA
PLoS ONE | www.plosone.org 13 April 2011 | Volume 6 | Issue 4 | e17936
Sequence types 573 and 772
Sequence types 573 and 772 belong, according to the MLST
database, to CC1. However, with respect to the pta allele these
strains differ from other CC1 (pta-12 or pta-22, respectively). Their
hybridisation profile is also distinct, which may be attributed to
one or multiple recombination events that have introduced genes
from other CCs into CC1. This includes agr (group II rather than
III), genes encoding the capsule type (5 rather than 8), the egc
enterotoxin gene cluster, and the enterotoxin homologue ORF
CM14. The enterotoxin H gene seh, which is otherwise typical for
CC1 strains, cannot be detected in ST573/772. The genes cna and
sasG are present. Protease genes splA, splB and splE are absent.
A PVL-negative ST573-MRSA-V strain has been described
from Australia (WA MRSA-10, [72]).
PVL-positive ST772-MRSA-V, which is known as WA MRSA-
60 or the Bengal Bay Clone [111], is relatively multi-resistant
compared to other CA-MRSA. In addition to a SCCmec V
(specifically, a VT [127]) element, they carry variably blaZ, erm(C),
msr(A), mph(C), aacA-aphD, aphA3, sat and tet(K). Besides the PVL
genes, all isolates tested harbour sea, and most carry sec and sel.
This strain was found by the authors in Australia, Germany, the
UK, Hong Kong and Abu Dhabi. German and British patients
usually had a travel history or family background suggesting an
infection in India or Bangladesh ([111], H.J. Linde, Regensburg,
Germany, pers. communication, and own observations) where it
appears to be increasingly common [104].
Sequence type 779
ST799-MRSA has been found sporadically by the authors in
the UK, Ireland, France and Australia. Isolates harbour a C2 mec
gene complex (mecA, ugpQ) but carriage of ccr genes varies
(‘‘ccrAA’’+ccrC or ‘‘ccrAA’’+ccrA/B4, or no detectable recombinases).
Q6GD50 is detectable, possibly indicating a combination of
SCCmec and SCCfus elements. ST779-MRSA are PVL-negative,
but carry etD and edinB.
Sequence type 834
According to the MLST database, ST834 belongs to CC9.
However, microarray hybridisation profiles differ from other CC9
strains in several key features such as agr allele (agr group I rather
than II), capsule type (8 rather than 5), spa type, presence of sasG
and alleles of some MSCRAMM genes (bbp, map, vwb). ST834-
MRSA-IV occurs rarely in Australia, where it has been described
as WA MRSA-13. The tested isolates harbour tst1, sec and sel, but
lack PVL genes. PVL-negative ST834-MRSA-IV also has been
observed in Cambodia [165].
Clonal complex 913
A single isolate of a ST913-MRSA-IV was identified by the
authors from a Lebanese refugee in Germany who suffered from
haemorrhagic bronchitis. It is positive for two genes encoding
exfoliative toxins (etA and etD) as well as for edinB. It lacks
enterotoxins and PVL. A recent paper [39] on MRSA isolates
from the Negev region of Israel suggests a wider distribution of this
strain in the Middle East as well as the presence of closely related
ST912 and ST914.
Sequence type 1048
This sequence type has only been reported in Hong Kong
where it was sporadically isolated in nursing homes [125]. The
authors found a single isolate from Hong Kong. ST1048 is related
to CC7, but differs in some markers including the presence of sasG
and cna, and the alleles of arcC and spa. It has spa type t1081, which
can also be observed in CC45 and ST1774. The tested isolate
carries SCCmec IV, ccrC, and ACME. It is negative for PVL and
enterotoxin genes, but a previous study [125] indicated the
presence of egc genes seg and sei in some isolates of this ST.
Sequence type 1774
This strain was isolated from several patients in Hong Kong and
has not been described previously. It shares spa type t1081 with
other clones (CC45 and ST1048, see [125]). Isolates carry SCCmec
IV, ccrC, and ACME. PVL and enterotoxin genes cannot be
detected. Variable resistance markers include the b-lactamase
operon and qacC.
Discussion
Strain definition and nomenclature
Genes of the ‘‘core genome’’ and the ‘‘core variable genome’’
[219] yield essentially the same phylogenetic information as the
seven housekeeping genes used for MLST. Consequently, a
MLST clonal complex can be identified by microarray hybridisa-
tion based on a characteristic fingerprint pattern [96], provided
that a hybridisation pattern for this CC has been defined
previously. For CC assignment, the presence or absence of sasG,
cna, fosB, lukD+lukE, egc, seh, ORF CM14 as well as the
identification of the actual allelic variant of genes of the agr, ssl/
set, hysA, hsdS, and capsule loci and of genes encoding
MSCRAMMs, proteases and a leukocidin homologue (‘‘lukY’’)
are used [96]. Whilst clonal complex affiliation can be easily
determined, the assignment to ‘‘strains’’ is not that straightfor-
ward. The concept of the ‘‘strain’’ can be beneficial for infection
control purposes and subsequently, a wide variety of different
epidemic or pandemic MRSA strains have been described.
Unfortunately, different criteria and different methods have been
applied for defining and naming MRSA strains. This has resulted
in a confusing situation with several strains having multiple
designations. For instance, ST5-MRSA-II is known as the Rhine-
Hesse Epidemic Strain in Germany, UK-EMRSA-3 in the UK,
USA100 in the USA, CMRSA-2 in Canada, AR07.3, AR07.4 or
AR11 in Ireland, and New York-Japan Clone in Australia and
elsewhere. For this reason, Enright et al. [220] proposed to
designate strains by ‘‘sequence type-MRSA-SCCmec type’’ such as
‘‘ST5-MRSA-II’’. We largely followed this principle. However,
this nomenclature has shortcomings if clearly different strains have
the same ST and SCCmec type (such as the various ST8-MRSA-
IV). Additional information, such as PVL status or carriage of
superantigens, is of relevance in defining the ‘‘pathotype’’ of the
organism, which is important for clinical management purposes.
Thus, PVL-positive and PVL-negative strains of the same ST and
SCCmec affiliation are treated separately here, as their clinical
significance may be different.
Another challenge, beyond the definition of individual strains, is
that the concept of a ‘‘strain’’ in itself cannot properly be defined.
Traditionally a strain has been defined as ‘‘an isolate or group of
isolates that can be distinguished from other isolates of the same
genus and species by phenotypic characteristics or genotypic
characteristics or both’’ [221;222], which is essentially the same as
a clone which is defined as a group of ‘‘isolates that are
indistinguishable from each other by a variety of genetic tests’’
[221;222]. Thus, the definition of a clone or strain depends on the
discriminatory power of the test and/or on the number of different
tests applied. Isolates which appear to be indistinguishable by, e.g.,
PFGE might yield differences detectable by microarray hybrid-
isation or genome sequencing. In the case of S. aureus, all
previously defined strains can be subdivided into a considerable
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number of variants as they harbour variable genes in different
combinations [29;43;82]. Of course, it is not practical to regard all
these variants as ‘‘strains’’ and to invent and to use different names
for, e.g. the variants of ST22-MRSA-IV which just differ in
carriage of erm(C) or sec+sel. However, UK-EMRSA-2 and UK-
EMRSA-6 (both CC8-MRSA-IV) are regarded as different
‘‘strains’’ although they differ only in the presence of aphA3 and
sat, neither of which are particularly important from a clinical
perspective. Similarly, Vienna and Hungarian epidemic strains
differ basically in the presence of tet(K). On the other hand, isolates
which are known as the Hannover Epidemic Strain could easily be
divided into two ‘‘strains’’ based on their different SCCmec
elements. In fact, a ‘‘strain’’ may be of polyphyletic origin. MSSA
from different branches of one clonal group may have acquired
the same SCCmec element independently on several occasions.
This has previously been proposed in the case of ST5-MRSA-II
[46]. These few examples emphasise the fact that the concept of
‘‘strains’’, although convenient and practical, is in fact a rather
arbitrary approach of forcing taxonomy on permanently changing
and evolving biological subjects. When scrutinised by methods
such as genome sequencing or microarray hybridisation, ‘‘strains’’
are not static blocks comprised of identical isolates, but rather
consist of groups of isolates with similar sequences. These
sequences might differ in single point mutations (as sometimes
obvious in MLST, e.g., Taiwan Clone isolates may have different
gmk alleles), in the composition and sequence of single loci (such as
the variable part of the spa gene or the dru region within the
SCCmec element) or in the presence or absence of complete genes
or multi-gene mobile elements. Thus, the concept of ‘‘quasispe-
cies’’ [223-227] could be applied in which the genome ‘‘cannot be
described as a defined structure, but rather as a weighted average
of a large number of individual sequences’’ [228]. The difference
between S. aureus and the RNA-viruses (to which this concept has
been applied first [228]), is basically the time frame in which
variations evolve. Conveniently, the extent and time frame of
variability in S. aureus provide ample opportunities for typing, i.e.,
for outbreak investigations and infection control purposes.
Biodiversity of MRSA and SCCmec elements
For more than three decades, MRSA was mainly an issue of
hospital hygiene and infection prevention and control. Interest-
ingly, the ‘‘older’’ SCCmec elements found in HA-MRSA strains
have largely been observed in and restricted to a few genotypes,
mainly to CC5 and CC8. CC5 and CC8 harbour the widest
diversity of SCCmec elements, and some of the most recently
described types have only been found in these CCs (Figure 5). This
is not related to their overall abundance, i.e., to the statistical
probability of a gene transfer event. In contrast, MRSA from the
equally abundant CC15 [94] has only been described once, some
30 years ago [33]. Thus, SCCmec elements from other species may
be more readily integrated into CC5 and CC8 than into other S.
aureus lineages. These two CCs might serve as some kind of ‘‘entry
gate’’ of SCCmec elements into the S. aureus gene pool from which,
possibly after some adaptations, these elements can be transferred
into other S. aureus lineages. The reason for this is unclear, but
peculiarities of, e.g., lineage-specific restriction-modification sys-
tems which can control horizontal gene transfer into S. aureus and
between different S. aureus could be scrutinised with in this regard.
The epidemiology of MRSA has changed over the last two
decades with the rise of CA- and LA-MRSA harbouring a
previously unknown variety of SCCmec elements. It is tempting to
speculate that the rise of new strains was not only paralleled, but
triggered by the emergence of these elements, especially of
SCCmec IV. Compared to other SCCmec elements, SCCmec IV
can be found in a wide diversity of different S. aureus clonal lineages
(Figure 5). Interestingly, it is also the most common SCCmec
element in S. epidermidis. It has been detected in approximately
40% of methicillin-resistant S. epidermidis from humans, which
belonged to wide variety of genetic backgrounds [229]; and it is
also common among coagulase-negative staphylococci from
animals [230]. The evolutionary success of this element might
suggest either a better ability to be transmitted between different
strains, and even species, and/or lower fitness costs [7;8].
Recently, a variety of ‘‘atypical’’ SCCmec elements have been
observed, some of which are described in this study. Whether they
are variants of previously known types or entirely new elements
still needs to be determined. However, these observations indicate
that the spread and evolution of SCCmec elements is still ongoing.
This prompts the question of where novel elements originated
from. Apparently, these elements evolve independently of the S.
aureus genome they actually reside in. Different SCCmec elements
may be observed in otherwise virtually identical strains, and strains
from completely different clonal complexes may acquire the same
SCCmec elements. Similar to other mobile genetic elements they
could be considered as ‘‘selfish genes’’ [231], i.e., as parasitic pieces
of genetic information which undergo their own evolution and
compete against each other, as previously discussed by Novick
(‘‘Mobile genetic elements are arguably selfish in that their
evolution is driven by selective forces that operate on the elements
themselves, independently of the host organisms within which they
must of necessity reside’’ [193]). However, contrary to other
‘‘selfish’’ mobile genes (such as endogenous retroviruses in
eukaryotic genomes) they confer an advantage to their ‘‘host
organism’’ by introducing antibiotic resistance properties and even
additional virulence factors such as a recently discovered phenol-
soluble modulin [232]. The relative independence of such
elements from host genomes also allows them to reside in other
species, and, indeed, a wide range of SCCmec elements can be
found in other staphylococci [229]. These bacteria provide an
ample pool of additional hosts for the SCCmec elements, and it can
be expected that novel elements may be transferred from other
staphylococci to S. aureus. For that reason, the evolution of
antibiotic resistance in bacteria infecting/colonising livestock is
highly relevant. Many animal species harbour S. aureus as well as
their own host-specific staphylococci (such as S. hyicus in swine or S.
pseudintermedius in dogs). Global livestock populations now exceed the
populations of most wild animals which might serve as hosts for S.
aureus. For example, there are 1,300 million cattle, 900 million pigs,
500 million cats and 400 million dogs in the world [http://www.
cattle-today.com/, http://en.wikipedia.org]. Because of their close
proximity to humans, domestic animals might serve as reservoir for
new strains as well as for novel SCCmec elements. While some
animal-specific S. aureus such as ST151 have so far failed to evolve
intoMRSA or to infect humans, others have truly zoonotic potential
with the best documented example being ST398-MRSA-V.
The role of Panton-Valentine leukocidin
Although PVL has been known for a long time [10;233], its
occurrence in MRSA strains is a recent phenomenon. Since PVL
is phage-encoded, it can be found in S. aureus belonging to many
different clonal complexes. Occurrence in diverse MSSA has been
discussed previously [113]. PVL-positive MRSA are found in
clonal complexes or sequence types CC1, CC5, CC8, CC22,
CC30, CC59, ST72, CC80, CC88, ST93, ST154, ST398 and
ST772 (Figure 5). Additionally, PVL-positive ST45-MRSA have
recently been reported [45;122]. As with SCCmec elements, PVL
phages undergo a host-independent evolution. As a set of ‘‘selfish
genes’’ they evolved to confer a selective advantage to their
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staphylococcal hosts in helping them to cope with the immune
defences of the vertebrates in which these staphylococci parasitize.
Thus, these phages compensate their staphylococcal host for the
fitness costs they may cause. This strategy appears to be
evolutionary successful as it evolved on multiple occasions.
Staphylokinase-encoding phages in S. aureus can be regarded as
another example. Staphylokinase improves the fitness of S. aureus
in the human host by facilitating their entry into deeper host
tissues and by inhibiting host defensins [234]. SCCmec elements
also ‘‘pay’’ for being transmitted and multiplied by helping their
staphylococcal hosts to cope with antibiotic compounds, which in
a certain sense also belong to the defences of the human host
against staphylococcal infection.
Some of the recently emerged PVL-positive MRSA strains are
known to occur and predominate in certain regions such as
USA300 in the USA, ST80-MRSA-IV in Europe and the Middle
East, ST772-MRSA-V in India, ST59-MRSA-VT in Taiwan and
ST93-MRSA-IV in Australia. Cases outside these regions are
increasingly being reported. In part, this can be attributed to
human travel activities. Other PVL-positive strains have been
found in multiple distant settings (e.g., ST22-MRSA-IV in Bavaria,
Germany, in Australian patients of Indian origin, in Abu Dhabi
and in Great Britain) which might suggest a polyphyletic origin
(see also [40]). Crudely, three different epidemiological situations
can be distinguished. First, in European countries (such as
Germany, [29;112]; the UK, [111]; Malta, [40] or Ireland,
[57;235]), the prevalence of PVL-MRSA is low and has remained
low for several years. In these countries, a variety of different
strains can be observed and individual cases can often be traced to
travel histories or to the foreign origin of patients. Thus, detection
of such strains in travellers might indicate an epidemic situation
elsewhere, and should prompt a thorough documentation of the
patient’s travel history. It may be speculated that an overwhelming
presence of successful PVL-negative clones (ST22-MRSA-IV and
ST398-MRSA-V) may hinder the dissemination of PVL-positive
clones. However, there are no data indicating whether these
strains would prevail in direct competition with a successful PVL-
MRSA-clone, and generally it is not known which properties
might render a strain ‘‘successful’’. Secondly, in Australia or Abu
Dhabi [31] PVL-MRSA are common and a number of different
strains co-exist. Since Australia as well as the Gulf Emirates
witnessed a recent and massive immigration of people from all
over the world, it can be assumed that these people have
introduced epidemic strains from their respective home countries.
For instance, USA300 may have come with North American
expatriates, or ST772-MRSA-V from India [111]. Thirdly,
another situation emerged in the USA, where a single strain of
PVL-MRSA (USA300) spread extensively and where this one
strain effectively marginalised all other strains, whether PVL-
positive or not [76]. Similarly, in Taiwan, most MRSA infections
Figure 5. Network graph based on hybridisation profiles, visualising similarities and relationships between clonal complexes and
the spread of SCCmec elements. Roman numerals indicate SCCmec types; PVL-negative strains are shown with black letters on white background,
PVL-positive in white letters on black. A, ACME; F, SCCfus; M, SCCmer; IRR, irregular SCCmec elements; COM, composite or multiple SCCmec elements.
doi:10.1371/journal.pone.0017936.g005
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are caused by ST59-MRSA-VT [14;236]. A comparable picture
may currently evolve in Australia due to a massive increase in
ST93-MRSA-IV infections.
The role of PVL in MRSA and especially in USA300 has been
extensively and controversially discussed [61;237-239], with
particular emphasis on the situation in the USA. However, other
parts of the world harbour other PVL-MRSA. If different strains
from diverse clonal groups cause the same distinct syndromes
(such as chronic/recurrent SSTI in immunocompetent young
adults) the causative factor should be present in all of them. Thus,
the observation that, e.g., PVL-positive CC5, CC8 and CC30
isolates can cause the same symptoms, but behave differently than
essentially isogenic but PVL-negative CC5, CC8 and CC30 strains
rendered it improbable that a factor other than PVL was the key
marker of virulence in PVL-positive MRSA. As PVL-MRSA
belong to different agr-groups, a connection of the evolutionary
success of PVL-MRSA to agr group affiliation, i.e., to peculiarities
of gene regulation is also improbable. The diversity and
abundance of PVL-MRSA clones in Abu Dhabi and Australia
could also indicate that no USA300-specific factor besides PVL
(such as ACME) was necessary for the expansion of a PVL-MRSA
clone. Thus, our observations suggest that PVL plays a key role in
the evolutionary success of MRSA in a clearly defined ecological
niche of chronic/recurrent SSTI in otherwise healthy young adults
and, rarely, of necrotising pneumonia. In settings where PVL-
MRSA is abundant, they also have been observed to cause, e.g.,
bloodstream infections [240]. However, this can be attributed to
their overall abundance and to the relative rarity of other strains,
since PVL is thought not to contribute to the pathogenesis of
bloodstream infections [241].
Outlook
The evolving issue of community-acquired and livestock-
associated MRSA poses a major public health threat. The
biological diversity of MRSA is increasing and this enables MRSA
to move out of the small and relatively controllable ecological
niche of hospitals and intensive care units into the general
population of developed and developing nations and into livestock
animals. Consequently, it can no longer be considered an exclusive
hospital-associated problem, and it cannot be fought by hospital
infection prevention and control measures alone. Some of the
MRSA strains may replace MSSA in a similar way as
penicillinase-positive strains replaced penicillinase-negative strains
in the 1950s and 1960s. A consequence of such a development
may be that b-lactam antibiotics could only be used when proven
to be effective, i.e. not as an initial therapy but only after
susceptibility testing has been performed. This would result in an
increased use of antimicrobials which are more expensive and/or
less effective and in dire consequences for individual patients as
well as for entire national healthcare systems.
Due to the increasing biodiversity of MRSA and the resulting
exploitation of novel ecological niches outside of hospitals it
cannot be realistically expected that MRSA might be eradicated
easily. In order to check its current proliferation, factors which
confer advantage to MRSA need to be turned into a
disadvantage. Thus, carriage of mecA and/or PVL needs to be
‘‘penalised’’ by consequent treatment, eradication and infection
prevention and control measures. Practically, a ‘‘search-and-
destroy’’ policy as in Scandinavian countries, the Netherlands
and Western Australia is warranted. This requires routine
screening assays for mecA and/or PVL as well as advanced typing
techniques and we anticipate that the methods and data from our
study might contribute to this.
Materials and Methods
Strains and isolates
A database of microarray experiments performed by the authors
on more than 3,000 MRSA isolates has been used for this study.
Isolates have been collected as part of routine diagnostic work
from the following sources: the Dresden University Hospital
(Saxony, Germany) and hospitals of Hoyerswerda (Saxony,
Germany) and Saarbru¨cken (Saarland, Germany), a variety of
German intensive care units (as part of the S.A.R.I. study, [242]),
the ‘‘Friedrich-Loeffler-Institut’’ (Federal Research Institute for
Animal Health, Germany), the national MRSA reference centres
in London (UK), Lyon (France) and Dublin (Ireland), hospitals in
Ireland, Msida (Malta), Abu Dhabi (United Arab Emirates), Hong
Kong (China), Trinidad & Tobago and from the Gram-positive
Bacteria Typing and Research Unit, Perth (Australia). The
majority of isolates were sampled between 2000 and August
2010. A small number of older isolates were also included (such as
for ST247- and ST250-MRSA-I); this is mentioned in the text
along with the strain descriptions. Additionally, a collection of
reference strains from the Network on Antimicrobial Resistance in
S. aureus (NARSA, Herndon, Virginia, USA) was characterised,
mainly to reflect the diversity of MRSA strains in the USA. A few
strains originated from other sources that are acknowledged in the
respective sections and in the Acknowledgments.
Additional information on emerging MRSA strains and their
geographic distributions as reported in recent publications has also
been included.
Sequence-based typing
Multilocus sequence typing (MLST), which is based on
sequencing of internal fragments of arcC, aroE, glpF, gmk, pta, tpi
and yqiL housekeeping genes, was performed on selected isolates.
The protocol used was as described by Enright et al. [25]. The
sequences obtained were compared with those at the MLST
website (http://saureus.mlst.net/) to assign a sequence type (ST).
Related sequence types were clustered to clonal complexes (CC)
using BURST analyses as provided on the MLST website.
The spa typing procedures were performed according to
previously published protocols [243] using the nomenclature as
described on the Ridom website (http://spa.ridom.de/) and either
the RIDOM or SPATYPEMAPPER (freeware, download at
http://www.clondiag.com/fileadmin/Media/Downloads/SPA
TypeMapper_0_6.zip) software packages.
DNA microarray-based typing
The Alere StaphyType DNA microarray was employed using
protocols and procedures previously described in detail [29; 96].
The DNA microarray covers 334 target sequences, (approximately
170 distinct genes and their allelic variants) including species
markers, SCCmec, capsule and agr group typing markers, resistance
genes, exotoxins, and MSCRAMM genes. Primer and probe
sequences have been published previously [29;96].
Target genes and information on primers and probes are
provided in Supplemental file S1.
MRSA were grown on Columbia blood agar and incubated
overnight at 37uC. Culture material was enzymatically lysed prior
to DNA preparation using commercially available spin columns
(Qiagen, Hilden, Germany). Purified DNA samples were used as
templates in a linear primer elongation using one primer per
target. All targets were amplified simultaneously, and within this
step, biotin-16-dUTP was incorporated into the resulting ampli-
cons. An alternate protocol was used for a few isolates in which
amplification and labelling were directed by random primers
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[139;244]. As this protocol does not rely on conserved primer
binding sites, it proved to be useful for characterisation of unusual
strains which are not fully represented by the published genome
sequences (e.g., ST75 strains).
Amplicons obtained using either protocol were hybridised to the
microarray followed by washing and blocking steps, and the
addition of horseradish-peroxidase-streptavidin conjugate. After
further incubation and washing steps, hybridisations were
visualised by using a precipitating dye. An image of the microarray
was taken and analysed using a designated reader and software
(ALERE Technologies GmbH, Jena, Germany). Normalised
intensities of the spots were calculated based their average
intensities and on the local background [96]. Results were
regarded as negative if the normalised intensity for a given probe
was below 25% of the median value of species markers (coa, eno,
fnbA, gapA, katA, nuc, rrn, sarA sbi, spa, vraS) and a biotin staining
control. If the normalised intensity of a given probe was higher
than 50% of this breakpoint, it was interpreted positive. If it was
between 25% and 50%, the result was regarded as ambiguous. For
some markers, for which allelic variants were to be discriminated
(bbp, clfA, clfB and fnbB as well as some set/ssl genes, isaB, mprF and
isdA), a different approach was used because these alleles differed
only in single nucleotides. Here, only the probe with the strongest
signal value was regarded as positive, provided that it exceeded the
50% breakpoint. All others were regarded as ambiguous or, if
below the 25% breakpoint, as negative. This allowed an easy and
clear distinction of clonal complex-specific variants of these genes.
Genes which are not present in all tested isolates are labelled as
rare, variable or common in Figures 2 and 3 as well as in
Supplement S2 (see legends).
The affiliation of isolates to clonal complexes (CCs) or sequence
types (STs) as defined by MLST [25] was determined by an
automated comparison of hybridisation profiles to a collection of
reference strains previously characterised by MLST [29;96].
Analysis of hybridisation patterns cannot discriminate sequence
types which differ only in single point mutations affecting MLST
genes (e.g., ST5 and ST225, or ST59 and ST952). However, there
are also sequence types which originate from chromosomal
replacements as previously described [170;173]. As these events
result in different hybridisation patterns, such STs can be easily
identified. MRSA strains which belong to these sequence types will
be described separately from the parental CCs.
SCCmec typing
The SCCmec elements were typed using previously described
PCR primers and conditions and by array hybridisation as
described below.
For PCR-based typing, structural architecture and mec-complex
were determined using the primers described by Zhang et al., 2005
[132]. SCCmec type IV was further sub-typed using published
primers [245]. The cassette chromosome recombinase (ccr) was
typed as described previously [246]. An ISau4-like transposase
(GenBank accession number DQ680163) inserted into the open
reading frame V011 of SCCmec VT was detected by the
production of a ca. 1,600-bp PCR and confirmed by sequencing
[126].
All Irish MRSA isolates underwent SCCmec typing for (i) the ccr
and mec complex genes and (ii) the J regions and mecI
[15;85;246;247]. In addition, isolates harbouring SCCmec IV
underwent SCCmec IV sub-typing. Sub-typing of variant SCCmec
II and IV elements from Irish isolates was performed as described
previously [15; 245].
The array includes probes for mecA, an accompanying gene,
ugpQ, mecI and xylR. Two different probes for mecR1 allow the
discrimination of un-truncated mecR1 and truncated mecR1
(DmecR1). Four different alleles of ccrA and ccrB (ccrA-1, ccrB-1,
ccrA-2, ccrB-2, ccrA-3, ccrB-3, ccrA-4 and ccrB-4) can be distin-
guished. The gene ccrC and a ‘‘hypothetical protein’’ accompany-
ing ccrC form an additional pair of recombinase genes. Because the
latter is an analogue to ccrA, it is here tentatively named ‘‘ccrAA’’.
Alleles from strain 85-2082 (GenBank AB037671) and strain
MRSAZH47 (GenBank AM292304) can be distinguished by
different probes. While all SCCmec V strains react with the former
probe, only a part of them yield signals with probes for the latter
variant. This includes strains ST398-MRSA-V and Taiwan Clone
ST59-MRSA-VT which are known to harbour a distinct variant,
SCCmec VT (5C2&5).
J-region genes dcs, pls-SCC and the kdp-operon can also be
detected. Other genes with relevance for SCCmec are a mercury
resistance operon, the tobramycin resistance gene aadD, the
macrolide, lincosamide and streptogramin B resistance gene
erm(A), the tetracycline resistance gene tet(K) and the fusidic acid
resistance marker Q6GD50. However, as these genes are plasmid-
or transposon-encoded, they are not necessarily restricted to
SCCmec elements. An overview on hybridisation patterns associ-
ated with the different SCCmec types is provided in Figure 1.
Tree reconstruction
In order to visualise similarities between hybridisation profiles, a
network tree using SplitsTree software [248] was constructed.
Array hybridisation profiles of the tested strains (Supplemental file
S3) were converted into a series of ‘sequences’ (Supplemental file
S5). Each position in this ‘sequence’, i.e., each probe, could have a
value of ‘positive’ (‘C’), ‘negative’ (‘G’), ‘ambiguous’ (‘A’) or
‘variable’ (‘T’) with the latter including all these markers which are
in Supplemental file S3 designated as ‘rare’, ‘variable’ or as
‘common’. These ‘sequences’ were used with SplitsTree version
4.11.3 on default settings (characters transformation: uncorrected
P/ignore ambiguous states, distance transformation: Neighbour-
Net, and variance: ordinary least squares). For CC15 and ST426,
data from MSSA [96] were used as no MRSA isolates were found.
The scale bar represents the number of differences between signal
strings (with 0.1 meaning 10% difference).
Due to the high rate of recombination affecting many genes
covered by the array, this tree does not reflect necessarily true
phylogenetic relations. However, the observation that strains of the
same clonal complex cluster together indicates that phylogenetic
relationships indeed result in similar hybridisation patterns and, on
a practical level, that the hybridisation profile can be used to
predict CC affiliation [96]. Similarly, also CCs which are related
according to sequence analyses (e.g., CC22, CC30, CC45 and
ST207, see [115]) also cluster together.
For comparison, a SplitsTree analysis of the concatenated
MLST sequences (Supplemental file S4) of all STs mentioned
herein is provided as Figure 4.
Supporting Information
File S1 Target genes, probes and primers.
(PDF)
File S2 Overview of sequence types (STs), spa types, some
characteristic genomic markers and fully sequenced genomes of
the clonal complexes (CCs) described in this study (bold typeset
indicates STs and spa types identified in the present study; italic
typeset indicates STs found by the authors in MSSA isolates or spa
types described in literature or public databases such as RIDOM;
*, see text for further explanation).
(PDF)
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File S3 Complete hybridisation results for MRSA strains
examined in this study.
(PDF)
File S4 "nexus"-file used for the network graph based on
concatenated MLST sequences (Figure 4).
(NEX)
File S5 "nexus"-file used for the network graph based on
hybridisation profiles (Figure 5).
(NEX)
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